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Chapter 1
Introduction
Viatmin A is an essential nutrient in the diet for normal growth, differentiation
(Wolback and Howe 1925), reproduction (Thompson, Howellet al. 1964), and vision
(Wald 1968). The major natural forms of vitamin A include retinol, retinal, and retinoic
acid (RA), which contain a conjugated double-bond system rendering them extremely
hydrophobic and thus quite water insoluble (Fig.1.1).Therefore, transport,
metabolism, and utilization of retinol and its derivatives requires the actions ofa diverse
class of retinoid binding proteins, which are present inserum and retinoid target tissues
(Soprano 1994).
Vitamin A is absorbed from the diet mainly from animalsources as retinyl
esters, although significant amounts are derived from plant carotenoid pigments, such as
p3-carotene (Soprano 1994). Within intestinal mucosal cells J3-carotene is converted via
a two-step process to retinol. On the other hand, retinyl esters are hydrolyzed in the
intestinal lumen and the resulting retinol is absorbed by the mucosal cells. Thus, retinol
is the major form of dietary vitamin A in animals.1
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Figure 1.1 Naturally occurring trans-retinoids.
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In intestinal mucosal cells, retinol is esterified with free fatty acids and
incorporated into chylomicrons for transport to the liver (Soprano 1994). Once in the
liver, retinyl esters can be stored or converted to retinol and transported to individual
target tissues with the aid of serum retinol binding protein (RBP). In the target tissue,
retinol is sequestered by a cellular retinol binding protein (CRBP), that facilitates its
conversion to the aldehyde, retinal (Leid in press).CRBP-retinal then serves as a
substrate for a retinaldehyde dehydrogenase enzyme, that catalyzes the irreversible
formation of RA (Leid in press). Vitamin A target tissues include virtually all tissues in
the body and, with the exception of the requirement of retinol for vision, and perhaps
reproduction, exogenous RA is able to replace vitamin A for all its functions (Giguere
1994). Thus, RA is believed to act as the primary active metabolite of vitamin A in the
regulation of development and homeostasis.
1.1Role of retinoids in growth and development
Retinoids are essential for normal growth as demonstrated by classic
experiments performed in the 1920s with vitamin A-deficient rats (Wolback and Howe
1925). Consequently, the occurrence of vitamin A deficiency under natural conditions
is mainly restricted to growing periods of the life cycle, i.e., gestation and early life.
Clues that retinoids play an important role in development came from observations thatEl
either a deficiency or an excess of retinoids inducessevere malformations of the
developing embryo. Indeed, retinoids aresome of the most potent natural teratogens
known, and studies of the teratogenic effects of retinoids have contributed towardsa
greater understanding of the specific roles of retinoids in development.
Experimental studies in rodents have demonstrated thatexposure to high
retinoid concentrations during development results insevere craniofacial abnormalities
(Roberts and Sporn 1984). These include malformation of the cartilagenous and bony
facial tissues, such as the mandible, palate, and maxilla,as well as the outer ear
(Roberts and Sporn 1984). These effects have also been observed in human fetuses
exposed to 1 3-cis-retinoic acid during gestation (Kraft 1992; Lammer and Armstrong
1992). In addition, malformations have been observed in hindbrainstructures as well as
the cardiovascular system (Kraft 1992; Lammer and Armstrong 1992). Of particular
note is the effect of RA on cells of mesenchymal origin. Treatment of 9-day-old rat
embryo explants with RA prevents formation of the pharyngeal arches that later give
rise to the mandible and maxilla (Morriss and Steele 1977). In addition, observations
that both an excess and deficiency of RA lead to the suppression of yolksac circulatory
tissue in embryo explants suggest that these mesenchymally derived cells requirea
narrow range of RA concentrations for proper development (Thompson, Howell et al.
1969; Morriss and Steele 1977). The concentrations of retinoids required to exert these
effects in vitro are very low, suggesting that the responsesare selective and do not arise5
due to a generalized toxic action on the embryo as a whole. These studies have
prompted speculation that RA may be a true morphogen in development by inducing in
a dose-related manner differentiation of cells in the embryo according to their position
relative to organizing regions.
Perhaps the most appreciated developmental process influenced by RA is limb
morphogenesis. During limb regeneration in urodeles, local application of RA can
respecify the positional memory of progenitor cells that arise at the amputation plane,
leading to regeneration of duplicated structures (Tabin 1991).For example, if
amputation occurs at the wrist, local application of high doses of RA results in the
regeneration of the entire arm, producing serial duplication of skeletal structures,
whereas lower concentrations of RA result in more proximal regenerates (Tabin 1991).
Similarly, RA has also been shown to affect the developing chick limb bud.
Application of RA to the limb bud results in a mirror-image duplication of the limb
pattern that is identical to the pattern resulting from grafts of posterior ZPA (zone of
polarizing acivity) tissue, which has been identified as an organizer (Tickle, Lee et al.
1985).It was demonstrated that RA induced the conversion of anterior cells into ZPA
cells, which in turn provided the actual pattern-duplicating stimulus (Wanek, Gardiner
et al. 1991). These studies have cast doubt on the role of RA as a true morphogen in
development, but rather suggest that RA induces formation of the organizer tissue,
which may then establish morphogenic gradients.1.2Retinoid regulation of cellular differentiation
It has been known for nearly 75 years that vitamin A exerts controlover cell
differentiation and proliferation. It was noted by Wolback and Howe, in their studies of
vitamin A deficiency in the rat, that vitamin Awas essential for the normal
differentiation of the epithelia (Wolback and Howe 1925). Vitamin A deficiency leads
to the conversion of secretory epithelial cells to a squamous, keratinizing phenotype
(Wolback and Howe 1925). Importantly, it was observed in organ culture that retinoid
treatment could reverse the keratinization of epithelial cells derived from vitamin A-
deprived animals (Sporn, Clamon et al. 1975). Later studies in vitamin A-deprived rats
fed with retinoic acid demonstrated that the deficiency adversely affects the rates of
differentiation of a subclass of mucous-secreting goblet cells (Rojanapo, Lamb et al.
1980).In contrast, epithelial tissues that normally lack goblet cells, such as skin,
exhibit a more pronounced keratinization, becoming thickened, dry, and scaly (Matoltsy
1976).In support of these findings, it was shown that retinoids could regulate the
terminal differentiation of epidermal cells, a change accompanied by marked alterations
in the pattern of keratin genes expressed (Fuchs and Green 1981; Kopan, Traska et al.
1987). Thus, vitamin A and its derivatives exert important control in the maintenance
and structure of epithelial tissues, mediated by its effects on cellular differentiation.
In addition to their role in promoting and maintaining epithelial cell
differentiation, retinoids have also been shown to induce growth arrest anddifferentiation in a number of cultured neoplastic cell lines including neuroblastomas,
melanomas, and teratocarcinomas (Roberts and Sporn 1984).Observed effects of
retinoids include inhibition of anchorage-independent growth and colony formation in
soft agar, induction of cell-cycle arrest, and promotion of terminal differentiationof
certain leukemias and embryonal carcinoma cells (Roberts and Sporn 1984).For
example, RA has been shown to induce terminal differentiation of the human myeloid
leukemia cell line HL6O to morphologically and functionallymature granulocytes
(Breitman, Selonick et al. 1980). The differentiating effects of RA in thissystem are
particularly impressive, as the potency of RA is several orders of magnitudegreater
than that of other known agents (Breitman, Selonick et al. 1980). Retinoidsare also
potent inducers of embryonal carcinoma cell differentiation. P19 cells (McBurney and
Rogers 1982) are a mutipotent mouse embryonal carcinoma cell line that have been
extensively utilized as a model system to study the effects of RAon differentiation.
P19 cells differentiate into all three primitive germ layers dependingon the growth
conditions and concentrations of RA administered (McBurney 1993). Whengrown in
a monolayer and treated with RA, P19 cells undergo differentiation along endodermal
and mesodermal pathways (Roguska and Gudas 1985). In contrast, RA hasa biphasic
effect on P19 cells grown in aggregates.When treated with low (1-10 nM)
concentrations of RA, P19 cell aggregates differentiate primarily via the endodermal
pathway while high concentrations (>300 nM) of this retinoid induce differentiationinto neurons, glial, and fibroblast-like cells (Jones-Villeneuve, McBurneyet al. 1982).
While many of the effects of retinoids on growth of transformed cellsare reversible,
effects on differentiation represent a stable alteration of the transformedphenotype to a
nonneoplastic phenotype. Therefore, the ability of retinoidsto induce differentiation of
various cancer cells make them particularly attractive therapeutic candidates.
Retinoid therapy has been approved for the treatmenta number of human
diseases, and is in early and late stage clinical trials for thetreatment of many others.
In fact, 13-cis-retinoic acid is currently the most effectivetreatment for acne vulgaris
and other skin diseases (Schaefer and Reichert 1990). In addition, clinical approval of
RA therapy in acute promyelocytic leukemia (APL)was a great advance, as RA
treatment leads to complete remission of this disease (Huang, Ye et al. 1988). Retinoid
treatment has also shown promise in the treatment of various other cancers of the head
and neck, cervix, and most other epithelial tissue-derivedcancers (Bollag and Holdener
1992). However, substantial drawbacks to retinoid therapyare the acute teratogenic
effects (described above) and other adverse side effects, includingsevere nausea and
skin irritations. Therefore, attempts are currently underway to design novel retinoids
with the aim of separating the therapeutic benefits of retinoids from the undesirable side
effects (Dawson and Okamura 1990).1.3Molecular mechanisms of retinoid action
Although much progress had been made in demonstrating the important role of
retinoids in the regulation of development and cellular function,a mechanistic basis of
the effects of retinoids was not uncovered until the discovery of nuclearreceptors for
RA. In 1987, two groups studying the superfamily of steroid hormonereceptors
identified a novel member of this family as the nuclearreceptor of RA, referred to as
RARa (Fig.1.2; Giguere, Ong et al. 1987; Petkovich, Brand et al. 1987), thus
implicating RA as a direct regulator of transcription. A second subtype, RAR,was
isolated shortly thereafter as the gene product encoded bya cDNA cloned from the
integration site of the hepatitis B virus in a human hepatocellular carcinoma (de The,
Marchio et al.1987).Subsequent isolations, using low-stringency hybridiztion
techniques, led to the isolation of the third member, RARy (Zelent, Krust et al. 1989).
It was later demonstrated that all three RAR loci generate multiple isoforms, differing
solely in their amino terminal region and arising through alternative splicingor
differential promoter usage (Giguere 1994). In agreement with the pleiotropic effects of
retinoids on cellular function, RARs are expressed in all tissues of the body, although
each RAR subtype exhibits restricted spatial and temporal patterns of expression in the
embryo and adult, suggesting that each RAR may perform unique functions (Leroy,
Krust et al. 1992).10
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Figure 1.2 Homology comparison of amino acid sequences of each
human RAR subtype. Amino acid residue positions (top) corresponding to
the boundaries between the different regions A-F, and percentage homology
are given for each comparison11
Shortly after the identification of the RARs, another family of RA-responsive
receptors belonging to the superfamily of nuclear receptors was identified, the RXRs
(Mangelsdorf, Ong et al. 1990; Mangelsdorf, Borgmeyer et al. 1992). Like the RARs,
the RXRs consist of three family members,a,and y subtypes (Fig. 1.3), each
encoded by separate genes that give rise to multiple isoforms differing in their amino
terminal regions (Mangelsdorf, Ong et al. 1990; Mangelsdorf, Borgmeyeret al. 1992).
Amino acid sequence comparisons revealing only weak homology with RARs, coupled
with observations that RXRs respond to somewhat higher concentrations of retinoic
acid, suggested that the natural ligand of the RXRs may not be all-trans-RA, butwas
likely closely related (Mangelsdorf, Ong et al.1990).These speculations were
confirmed when the RXR ligand was identified as the 9-cis-RA (9cRA) stereoisomer
(Heyman, Mangelsdorf et al. 1992; Levin, Sturzenbecker et al. 1992). 9cRA binds the
RXRs with high affinity and is present in vivo at significant levels, suggesting that
9cRAmay be the natural ligand (Heyman, Mangelsdorf et al.1992; Levin,
Sturzenbecker et al. 1992).
Mechanistic studies of the DNA binding strategies of steroid hormone receptors
revealed that these receptors bind their DNA response elementas homodimers (Kumar
and Chambon 1988). However, studies of the DNA binding properties of RAR and
other non-steroid nuclear receptors revealed that accessory factors present in the nuclear12
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Figure 1.3 Homology comparison of amino acid sequences of each human
RXR subtype. Amino acid residue positions (top) corresponding to the boundaries
between the different regions A-F, and percentage homology are given for each
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extracts of cell lysates were required for high affinity binding of thesereceptors to their
response elements. Observations that RAR and thyroid hormone receptor (T3R) could
form heterodimers in solution led to the hypothesis that theaccessory factor present in
the nuclear extracts might be members of the family of nuclearreceptors. Indeed, this
hypothesis was confirmed by a number of groups that discovered RAR familymembers
heterodimerize with RXR and bind all known retinoic acid responsive elementsas a
RAR-RXR heterodimeric complex (Yu, Delsert et al. 1991; Bugge, Pohlet al. 1992;
Leid, Kastner et al. 1992; Zhang, Hoffmann et al. 1992). Subsequentgene "knockout"
experiments have supported the hypothesis that the RAR-RXR heterodimer is the
functional unit transmitting the retinoid signal in vivo (Kastner, Grondonaet al. 1994),
as RARJRXR double knockout animals exhibit profound developmental defects that
resemble syndromes of severe vitamin A deficiency. In additionto binding to RARs,
RXRs form heterodimeric complexes with T3R, vitamin D receptor (VD3R), peroxisome
proliferator activated receptor (PPAR) and other orphan nuclearreceptors (Kliewer,
Umesono et al. 1992; Kliewer, Umesono et al. 1992; Kliewer, Umesonoet al. 1992;
Marks, Hallenbeck et al. 1992).Thus, one class of retinoid receptors, the RXRs,
function as coregulators of nuclear receptor function ina plethora of hormonal signaling
pathways.
The RARs and RXRs, like all nuclear receptors, sharecommon structural and
functional properties (Fig 1.4). These receptors exhibita highly conserved, modular14
structure composed of six regions designated A-F (Green and Chambon 1988). The
amino terminal A/B regions vary in length and have been shown to harbor a ligand-
independent transcriptional activation function.The highly conserved C region
comprises the DNA binding domain of these receptors and is composed of
approximately 66-68 amino acids that are organized into two C,H, zinc finger motifs
(Rastinejad, Perlmann et al. 1995; Rastinejad 2001). Region D comprises a hinge
region that harbors a nuclear localization signal, while the E region encompasses the
ligand binding domain (LBD) and also harbors an oligomerization domain. The LBD
of nuclear receptors is highly structurally conserved despite considerable divergence at
the amino acid level. This is highlighted by the fact that the RARs and RXRs, which
both bind 9-cis-RA with high affinity, exhibit only 28-33% amino acid identity in the
LDB between them.The LBD also harbors a ligand-dependent transcriptional
activation function, which results from the juxtaposition of several helices within the
LBD facilitating efficient interaction with transcriptional coactivator proteins.
Binding of ligand to RAR and/or RXR induces a substantial conformational
change in the receptors, resulting in rearrangement of helices within the LBD and
recruitment of a coactivator complex that harbors histone acetyltransferase (HAT)
activity (Xu, Glass et al. 1999). The coactivator complex is composed of proteins
harboring HAT activity, including p300/CBP, P/CAF, and the p160 family of proteins
(Xu, Glass et al. 1999). Transcriptional coactivators are thought to function by bindingReceptor function H2N A/B C D E
F
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Fig. 1.4 Anatomy of a nuclear receptor.
1516
to the nuclear receptor on the template and inducing a decondensation of chromatin
mediated by acetylation of the histones (Xu, Glass et al. 1999). This decondensation is
believed to be followed by dissociation of the coactivator complex and recruitment ofa
second class of coactivator complex to the ligand-bound receptors that harbor
components of the Pol II machinery, resulting in preinitiation complexes and
transcription (Ito and Roeder 2001).
In contrast to ligand-mediated activation of the receptors, unliganded-RAR-
RXR complexes are able to repress transcription through recruitment ofcorepressor
proteins to the template such as nuclear receptor corepressor (NcoR; Horlein, Naaret al.
1995) and silencing mediator of retinoid and thyroid receptors (SMRT; Chen and Evans
1995). NCoR and SMRT, in turn recruit a histone deacetylase (HDAC) complex to the
template (Huang, Zhang et al. 2000), resulting in deacetylation of lysine residueson
histones.Deacetylated histones are believed to have increased affinity for DNA,
resulting in the formation of more densely packed chromatin that is less likely to be
transcribed (Struhi, Kadosh et al. 1998).
Although the molecular basis of how retinoids induce changes in the pattern of
gene expression has become clearer, a full understanding of these changes as they relate
to cellular and developmental processes will require the identification and functional
characterization of the retinoid-induced target genes. A few RA-responsivegenes have
been identified to date. These genes encode transcription factors (La Rosa 1988; Song17
and Siu 1989; Kondo, Takahashi et al. 1992; Zwartkruis, Kruytet al. 1993; Bouillet,
Chazaud et al. 1995; Boudjelal, Taneja et al. 1997; Oulad-Abdeighani, Chazaudet al.
1997), metabolic enzymes (White, Guo etal.1996), growth factor receptors
(Kobayashi, Kurihara et al. 1994), extracellular matrix proteins (Gudas and Wang 1986;
Vasios, Gold et al. 1989) and secreted proteins (Smolich and Papkoff 1994;Oulad-
Abdeighani, Chazaud et al. 1998), however, asmany of these genes are novel and are as
yet not fully characterized, the totality of the mechanism of action of retinoids in the
control of developmental processes remains to be elucidated.
1.4ADP-ribosylation factors
In contrast to the retinoid signals, which are generally anti-proliferative and
promote cellular differentiation, signaling by members of the Ras superfamily of small
guanine nucleotide binding (G) proteins typically promotes cellular proliferation,
alteration in cellular morphology, or changes in vesicular trafficking pathways (Moss
and Vaughan 1998). ADP-ribosylation factors (ARFs) are members of this family that
regulate key aspects of membrane traffic in cells (Moss and Vaughan 1998). ARF
proteins are divided into three classes based on phylogenetic analysis,gene structure,
and molecular mass.The class I ARFs, which include ARFs 1-3,are the best
characterized and function in vesicular trafficking pathways in the Golgiapparatus(Serafini, Orci et al. 1991; Baich, Kahn et al. 1992), while littleis known about the
function of class II ARFs (ARFs 4-5). ARF6, the least conservedmember of the
family, comprises class III and regulates endocytic and actin remodelingpathways
(D'Souza-Schorey, Li et al. 1995; Radhakrishna, Klausneret al. 1996).
ARF proteins cycle between inactive GDP and active GTP-bound
conformations. The alternative conformations of ARFs, induced by GTP-binding and
subsequent hydrolysis of the bound nucleotide to GDP, facilitate interaction with, and
activation of various classes of effector proteins. As ARF proteinsare poorly able to
exchange GDP and hydrolyze GTP on their own, these reactionsare catalyzed by
GTPase activating proteins (GAPs) and guanine nucleotide exchange factors (GEFs),
respectively. An increasing number of proteins exhibiting ARF GAP activity have been
described (Donaldson 2000). Interestingly,many of these proteins harbor well defined
signaling motifs, such as ankyrin repeats, PH, proline-rich and SH3 domains, which
may link the ARF cycle to various signal transduction pathways. ARF GEFs, which all
share a conserved catalytic domain of approximately 200 amino acids that is
homologous to yeast Sec7 protein, fall into two categories basedon size and sensitivity
to inhibition by brefeldin A (BFA), a toxic fungal metabolite that blocks protein
secretion and Golgi function.19
1.5The cytohesin family of ARF GEFs
Members of the cytohesin family of proteins comprise the low molecular weight
BFA-insensitive ARF GEF category. The cytohesin family includes cytohesin- 1 (also
known as B2-1; Liu and Pohajdak 1992; Kolanus, Nagel et al. 1996), ARNO (ARF
nucleotide-binding site Qpener; also known as cytohesin-2; Chardin, Paris et al. 1996)
GRP1 (also known as ARNO3; Klarlund, Guilherme et al. 1997), and cytohesin-4
(Ogasawara, Kim et al. 2000). The cytohesins share a common domain structure
consisting of an amino-terminal coiled-coil domain, followed bya Sec7 domain that is
responsible for GEF activity, a pleckstrin homology (PH) domain that binds
phosphoinositides and aids in membrane recruitment, and a polybasic region at the
carboxyl terminus. Several laboratories have demonstrated a phosphatidylinositol 3-
kinase-dependent translocation of cytohesins to the plasma membrane of cells (Clodi,
Vollenweider et al. 1998; Nagel, Zeitlmann et al. 1998; Venkateswarlu, Guan-Moore et
al. 1998; Venkateswarlu, Oatey et al. 1998; Langille, Patki et al. 1999; Venkateswarlu,
Gunn-Moore et al. 1999; Klarlund, Holik et al. 2001).However, the cellular
consequences of 3'-phosphoinositide generation as it relates to the ARF cycle are
relatively unexplored.
Early studies that demonstrated cytohesins exhibited GEF activity on ARF1
(Paris, Beraud-Dufour et al. 1997), coupled with studies in transfected cells whichshowed that overexpression of ARNO and ARNO3 (GRP1) resulted in a disassembly of
the Golgi complex (Franco, Boretto et al. 1998; Monier, Chardin et al. 1998), led to the
conclusion that cytohesins function on class I ARFs. In support of these findings, a
Golgi targeting sequence was identified in the coiled-coil domain of the cytohesins (Lee
and Pohajdak 2000).In addition to their possible role in regulating ARF1 function,
recent studies have shown that cytohesins are able to activate ARF6in vitro(Frank,
Upender et al. 1998; Knorr, Nagel et al. 2000), in cultured cells (Langille, Patki et al.
1999), and colocalize with ARF6 in plasma membrane ruffles (Frank, Upender et al.
1998; Langille, Patki et al. 1999). While it has been demonstrated that cytohesins
display GEF activity on a variety of ARF subtypes, these results suggest that thein vivo
specificity of cytohesins with regard to ARF subtypes is likely mediated by the cellular
localization of the cytohesin.
1.6ARF6 regulation of plasma membrane recycling pathways
Overexpression analyses of GTP binding-defective (dominant negative, GDP-
bound) and GTPase-deficient (constitutively active, GTP-bound) ARF6 mutants in cells
have greatly contributed towards the functional elucidation of the ARF6 cycle
(D'Souza-Schorey, Li et al. 1995). D'Souza-Schorey and coworkers discovered a role
for ARF6 in receptor mediated endocytosis and plasma membrane recycling by21
analyzing transferrin receptor recycling in TRVb-1 cells expressing ARF6mutants
(D'Souza-Schorey, Li et al. 1995).Endocytic sorting and recycling pathways play
fundamental roles in the uptake of ligands at the cell surface and attenuation of
extracellular ligand-mediated signal transduction pathways (Waterman and Yarden
2001). It was shown that in cells expressing a GTPase deficient mutant of ARF6, ARF6
Q67L, transferrin receptors were localized exclusively to the plasma membrane along
with ARF6 Q67L and cells exhibited increased transferrin cell surface binding
(D'Souza-Schorey, Li et al. 1995). In contrast, cells expressinga GTP-binding deficient
mutant of ARF6, ARF6 T27N, exhibited a block in plasma membrane recycling as
transferrin receptors were internalized on endosomes with the ARF6 mutant, leadingto
a reduction in transferrin cell surface-binding (DSouza-Schorey, Li et al. 1995). These
results have led to the hypothesis that nucleotide exchangeon ARF6 occurs on
recycling endosomes, resulting in translocation and fusion of the endosomes with the
plasma membrane (Fig. 1.5; D'Souza-Schorey, Li et al. 1995; Peters, Hsu et al. 1995;
D'Souza-Schorey, van Donselaar et al. 1998). To complete the cycle, GTP hydrolysis
of ARF6 at the plasma membrane appears to be required for ARF6 to become
internalized and localize in the endosomal compartment (Fig. 1.5).
Despite evidence suggesting that nucleotide exchange of ARF6occurs on
endosomes, there are limited studies linking the cytohesins to ARF6-mediated22
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Figure 1.5. Regulation of plasma membrane recycling by ARF6.
GTPase activating protein (GAP)-catalyzed hydrolysis of ARF6-GTP
results in endocytosis and localization of ARF6-GDP on the endo-
some. The endosomes are next sorted and components that are des-
tined to recycle back to the plasma membrane may localize in a
juxtanuclear recycling compartment. In contrast, endosomal compo-
nents targeted for degradation are shuttled to the lysosome. Recruit-
ment of an ARF6 guanine nucleotide exchange factor (GEF) to the
endosomal compartment results in exchange of the bound GDP for
GTP on ARF6 and recycling of the endosome to the plasma mem-
brane.23
endosomal recycling. Franco and coworkers demonstratedthat overexpression of the
ARF6 GEF, EFA6, in TRVb-1 cells resulted ina redistribution of transferrin receptors
from intracellular vesicles to the plasma membrane (Franco,Peters et al. 1999), whereas
overexpression of ARNO3, the human homolog of GRP1,had no effect on the
distribution of transferrin receptors.Additionally, Maranda et al have shown that
ARNO and ARF6 are recruited to endosomes inkidney proximal tubule endothelial
cells in a pH-dependent manner (Maranda, Brownet al. 2001), suggesting that ARNO
may stimulate nucleotide exchange and recycling of the endosometo the plasma
membrane.
1.7 Research objectives
The goal of the studies described hereinwas to contribute towards a greater
appreciation of the molecular mechanisms of RA in exertingsuch profound effects on
cellular function. Towards that end, molecular techniqueswere employed to identify
and subsequently characterize a novel RA-inducedgene from P19 embryonal carcinoma
cells.
Chapter 2 describes the isolation ofa novel RA-induced gene, referred to as
GRASP, from P19 embryonal carcinoma cells.Experiments were conducted to
examine the expression profile of GRASP during RA-induceddifferentiation of P1924
cells, as well as the distribution of GRASP in the adultmouse. Yeast two-hybrid
screening was also performed with the aim of identifying interactionpartners of
GRASP. Preliminary studies were conducted examining the role ofGRASP in relation
to one of its newly identified interaction partners, the general receptor for
phosphoinositides 1 (GRP1).
Chapter 3 describes more detailed studies identifying the role of GRASP in
plasma membrane recycling pathways regulated by ARF6 and GRP 1.Specifically, the
effect of GRASP overexpression on this pathwaywas examined. Deletion analyses
were carried out to identify the regions in GRASP and GRP1 responsible for regulation
of the plasma membrane recycling pathway.
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2.1 Abstract
A novel, retinoic acid (RA)-induced gene, GRP 1-Associated ScaffoldErotein
(GRASP), was isolated from P19 embryonal carcinoma cells usinga subtractive
screening strategy. GRASP was found to be highly expressed in brain andexhibited
lower levels of expression in lung, heart, embryo, kidney andovary. The predicted
amino acid sequence of GRASP is characterized by severalputative protein-protein
interaction motifs suggesting that GRASPmay be a component of a larger protein
complex in the cell. Although GRASP does not harbora predicted membrane spanning
domain(s), the protein was observed to be associated with the plasma membraneof
transiently transfected mammalian cells.Yeast two-hybrid screening revealed that
GRASP interacted strongly with the generaleceptor forhosphoinositides I (GRP1),
a brefeldin A-insensitive guanine nucleotide exchange factor for the ADP-ribosylation
factor (ARF) family of proteins. GRASP.GRP1 interactionswere also demonstrated in
vitro and in mammalian cells in which GRASPwas shown to enhance URP1
association with the plasma membrane.Furthermore, GRASP colocalized with
endogenous ARFs at the plasma membrane in transfected cells suggesting that GRASP
may modulate signaling by this family of small GTPases.r1
2.2Introduction
Retinoic acid (RA) exerts important effects in theprocesses of vertebrate
development, cellular growth and differentiation, and homeostasis(reviewed in Gudas
1994).Cellular effects of RA are mediated by two families of nuclearreceptors,
retinoic acid (RAR) and retinoid X (RXR) receptors, both of whichare members of the
steroid/thyroid hormone receptor superfamily of ligand-dependenttranscription factors
(reviewed in (Chambon 1996). Retinoid signals induce the expression ofa wide array
of target genes implicated in mediating the pleiotropic effectsof RA on cellular
function. These genes encode transcription factors (LaRosa and Gudas 1988;Song and
Siu 1989; Kondo, Takahashi et al. 1992; Zwartkruis, Kruytet al. 1993; Bouillet,
Chazaud et al. 1995; Boudjelal, Taneja et al. 1997; Oulad-Abdeighani, Chazaudet al.
1997), metabolic enzymes (White, Guo et al.1996), growth factor receptors
(Kobayashi, Kurihara et al. 1994), extracellular matrix proteins (Gudas and Wang 1986;
Vasios, Gold et al. 1989), and secreted proteins (Smolich and Papkoff 1994;Bouillet,
Oulad-Abdeighani et al. 1996; Oulad-Abdeighani, Chazaud et al. 1998) postulatedto
convey positional information in the developing embryo.
P19 embryonal carcinoma (EC) cells (McBumey and Rogers 1982) have been
widely used as a model of RA-induction of cellular differentiationas these cells have
the capacity to differentiate into all three primitivegerm layers under the appropriate
cell culture conditions and inducers (McBurney 1993). Whengrown in a monolayer37
and treated with all-trans-retinoic acid (T-RA), P19 cells undergo differentiation along
endodermal and mesodermal pathways (Roguska and Gudas 1985). Incontrast, T-RA
has a biphasic effect on P19 cells grown in aggregates. When treated with low (1-10
nM) concentrations of T-RA, P19 cell aggregates differentiate primarily via the
endodermal pathway while high concentrations (>300 nM) of this retinoid induce
differentiation into neurons, glial, and fibroblast-like cells (Jones-Villeneuve,
McBurney et al. 1982). Additionally, P19 cell aggregates treated with DMSO (0.5-
1.0%) differentiate into skeletal and cardiac muscle cells (McBurney, Jones-Villeneuve
etal. 1982).
In contrast to the retinoid signals, which are generally anti-proliferative and
promote cellular differentiation, signaling by members of the Ras superfamily of small
guanine nucleotide binding (G) proteins typically promote cellular proliferation,
alteration in cellular morphology, or changes in vesicular trafficking pathways (Moss
and Vaughan 1998). ARF1 through ARF6 proteins are members of the Ras superfamily
that are implicated in the control of various vesicular trafficking pathways (Moss and
Vaughan 1998) and may also be involved in cytoskeletal reorganization and
morphological phenotypy (Radhakrishna, Klausner et al. 1996; D'Souza-Schorey,
Boshans et al. 1997).Activation of ARF proteins occurs as a result of GDP/GTP
exchange, a reaction catalyzed by guanine nucleotide exchange factors (GEEs). ARFGEFs fall into two broad categories, defined primarily by molecularmass and
sensitivity to inhibition by brefeldin A (BFA; (Moss and Vaughan 1998),a toxic fungal
metabolite that inhibits ARF nucleotide exchange (Donaldson, Finazziet al. 1992).
Cytohesin-1 (also known as B2-l; (Liu and Pohajdak 1992; Kolanus, Nagel et al. 1996),
ARNO (F nucleotide-binding-site Qpener; also knownas cytohesin-2; (Chardin,
Paris et al. 1996), and GRP1 (Klarlund, Guilherme et al. 1997)represent a recently
identified subfamily of ARF GEFs that are insensitive to the effects of BFA. These
GEF proteins share a common domain organization and exhibita high degree of overall
sequence similarity (80-90% amino acid identity). The catalytic activity of these GEFs
is greatly enhanced by binding of phosphoinositides (Chardin, Paris et al. 1996; Meacci,
Tsai et al. 1997; Klarlund, Rameh et al. 1998; Pacheco-Rodriguez, Meacci et al. 1998),
which is thought to induce GEF translocation to membranes (Paris, Beraud-Dufour et
al. 1997; Klarlund, Rameh et al. 1998) thereby facilitating subsequent interactions with
ARFs.
Although the cellular functions of the cytohesin subfamily members are not well
understood, conflicting data point to two functional consequences of activation of ARFs
by these BFA-insensitive GEFs. Because it was initially shown that these GEFswere
able to catalyze GDP/GTP exchange on ARF 1, which is known to be involved in ER-
Golgi and intra-Golgi transport (Donaldson, Cassel et al. 1992; Robinson and Kreis39
1992), attempts were made to analyze the cellularconsequences of overexpression of
these proteins on the function of the Golgi apparatus. Monier and coworkers (Monier,
Chardin et al. 1998) have shown that overexpression of ARNO (cytohesin-2) leadsto a
disassembly of the Golgi complex in transfected HeLa cells,a phenomenon that has
also been observed upon treatment of cells with BFA (Donaldson, Casselet al. 1992).
Similar effects have been observed in BHK-21 cellsupon overexpression of ARNO3,
the human homologue of GRP1 (Franco, Boretto et al. 1998). However, endogenous
ARNO does not cofractionate with Golgi membranes, but rather doesso with plasma
membrane markers (Frank, Upender et al.1998).Furthermore, it has been
demonstrated that ARNO colocalizes at the cell periphery with ARF6 in transfected
cells (Frank, Upender et al. 1998).In a later study, ARNO was demonstrated to
function as a GEF for ARF6 in transfected HeLa cells as evidenced by its ability to
induce remodeling of the cortical actin cytoskeleton (Frank, Hatfield et al. 1998),a
known function of ARF6 (Radhakrishna, Klausner et al. 1996).Similar results
implicating GRP1 as a GEF for ARF6 were obtained by other laboratories (Clodi,
Vollenweider et aL 1998; Langille, Patki et al. 1999).
With the aim of identifying potential target genes that mediate the effects of tRA
on induction of cellular differentiation, we isolated cDNAs corresponding to
differentially expressed mRNAs from P19 cells treated with tRA. We report herein thecloning, expression, and characterization of a novelgene that is induced by tRA in P19
cells. GRASP is strongly upregulated by tRA in P19 cells and the protein encoded by
this gene displays a plasma membrane localization. GRP1was isolated as a GRASP
interaction partner and GRASP was shown to colocalize with both GRP1 and ARFsat
the plasma membrane of transfected HEK293 cells.Coexpression of GRASP and
GRP1 resulted in an increased partitioning of GRP1 into the particulate fraction of cells
suggesting that the two proteins are part of a stable complex at the plasma membrane.
The presence of putative protein-protein interaction motifs within GRASP is highly
suggestive that GRASP may function as an adaptor or scaffolding protein. Wepropose
that GRASP may aid in thelocalization of GRP1 to discrete signaling networks and
facilitate stimulation of ARF mediated events at the plasma membrane.
2.3Materials and Methods
2.3.1Cell Culture and Transfections
P19 cells were cultured and treated with tRA essentially as described (Berg and
McBurney 1990). Human embryonic kidney (HEK) 293 cells were maintained and
transfected as described previously (Avram, Ishmael et al. 1999).41
2.3.2Plasmid Constructs
Vectors for the yeast two hybrid system (pBTM1 16 and pASV; Le Douarin,
Pierrat et al. 1995), the yeast reporter strain L40 (Le Douarin, Pierratet al. 1995), and
the random primed mouse embryo cDNA library inserted into the VP16 activation
domain (AD)-encoded pASV3 vector (Le Douarin, Pierrat et al. 1995)were all kind
gifts from Drs. R. Losson and P. Chambon (IGBMC, Illkirch, France). The GRP1
construct was kindly provided by Drs. Michael Czech and Jes Klarlund (Kiarlund,
Guilherme et al. 1997).All constructs were prepared using standard techniques.
Supplemental details are available upon request.
2.3.3Subtractive Hybridization and cDNA Cloning of GRASP
Subtractive hybridization was performed as described (Bouillet, Oulad-
Abdelghani et al. 1995). Full-length GRASP was isolated froma mouse embryo cDNA
library (10.5 days post-coitum) that was kindly provided by Dr. P. Chambon and J.-M.
Gamier.
2.4.9 Isolation of RNA and Northern Blot Analysis
Total RNA was isolated using TRI-REAGENT (Molecular Research Center)
according to the manufacturer's protocol. Poly (A)+ RNA was isolated by two rounds
of purification on oligo(dT) cellulose (Pharmacia Biotech). For northern analyses, 5-1042
tg of poiy (A)+ RNA were separated on a 1% agarose-formaldehyde gel, transferred to
a ZetaProbe (Bio-Rad) membrane and probed with a[32P]dCTP-labeled cDNA
fragments. Multiple exposures of the blots were used for quantitative densitometric
scanning using the MCID Imaging software as previously described (Leid 1994).
2.3.5Yeast Two-Hybrid Screening and 3-galactosidase Assays
Yeast two-hybrid screening and 3-galactosidase assays were performed
essentially as described (Dowell, Ishmael et al. 1997) except that the Sacchromyces
cerevisiae L40 reporter strain contained the bait plasmid pBTM1 16/GRASP 180-257.
2.3.6GST Pull Down Experiments
GST fusion proteins were produced, crude bacterial lysates were prepared and
GST pull down experiments were conducted as previously described (Dowell, Ishmael
etal. 1997).
2.3.7Reverse Transcription-Polymerase Chain Reaction Assays
RT-PCR and Southern analysis were performed as described (Avram, Ishmael et
al. 1999) using appropriate primers and probes. Detailed information is available upon
request.43
2.3.8Production of GRASP Polyclonal Antibodies
Antisera was raised in the goat against purified GST-GRASP by Bethyl
Laboratories (Montgomery, TX). The anti-GRASP antisera was affinity purified by
passing serum from the immunized goat multiple times over a GST immunosorbent to
absorb anti-GST antibodies.The serum was then passed over a GST-GRASP
immunosorbent to capture antibodies specific for GRASP and this column was eluted at
low pH. The extent of anti-GST contamination in the affinity purified ant-GRASP
antisera was found to be less than 5%.
2.3.9Indirect Immunofluorescence and Confocat Microscopy
Twenty-four hours following transfection, HEK293 cells growing on coverslips
were fixed in 4% paraformaldehyde and permeabilized in two changes of PBS + 0.02%
Triton-X-100. Antibody incubations were performed using standard techniques with
the anti-Myc monoclonal antibody (Invitrogen), anti-GRASP polyclonal antibody, or
the monoclonal antibody 1D9 (kindly provided by Dr. Richard Kahn), which has been
reported to recognize all human ARF proteins (Cavenagh, Whitney et al. 1996). Myc-
GRASP immune complexes were detected using fluoroscein isothiocyanate (FITC)- or
tetramethyirhodamine isothiocyanate (TRITC)-congugated goat anti-mouse antibodies
(Southern Biotechnology Associates Inc.).FITC-congugated rabbit anti-goat and
TRITC-congugated rabbit anti-mouse were used as secondary antibodies for thedetection of anti-GRASP and 1D9, respectively. Imageswere captured on a Leica
inverted confocal microscope model TCS4D and processedusing Photoshop 5.0
(Adobe Systems, Inc.)
2.3.10Preparation of HEK293 Extracts and Immunoblotting
Cytoplasmic and membrane extracts of HEK293 cellextracts were prepared
essentially as described (Hansen and Casanova 1994). Twentymicrograms of protein
from the various extracts were subjectedto immunoblot analysis as described
previously (Leid 1994) using anti-Myc (Invitrogen)or anti-GFP (Clontech) monoclonal
antibodies.For coimmunoprecipitation analysis, HEK293 cellswere collected in
solubilization buffer (10 mM Hepes pH 7.4, 150 mM NaC1, 1mM EDTA,1 mM DTT,
10% (v/v) glycerol, 0.1 mM PMSF, 10 .tM pepstatin A, 10 .tMleupeptin, 25 .tg/ml
aprotinin, 0.05% (v/v) NP-40 and 0.5% (v/v) Triton-X-100) andincubated at 4°C with
rotation for 30mm.The lysate was cleared by centrifugation at 16,000x g for 20 mm.
at 4°C. Three hundred micrograms of lysate proteinwas incubated with the anti-Myc
antibody in a volume of 1.5 mL for 30 mm.at 4°C, after which a rabbit anti-mouse
secondary antibody(Southern Biotechnology Associates,mc)was added and the
incubation continued for an additional 30mm.Protein A-Sepharose (100 liL, 50 mg/mm
in solubilization buffer; Pharmacia) was then added and the incubationwas continued atin solubilization buffer; Pharmacia) was then added and theincubation was continued at
4°C with rotation for an additional 30 mm. The beadswere collected by centrifugation
(800 x g for 1 mm. at 4°C) and subsequently washed gently six timeswith 1.0 mL
solubilization buffer. Immunoprecipitateswere subjected to immunoblot analysis as
described above.Various exposures of the blots were used for quantitative
densitometric scanning as previously described (Leid 1994).
2.4Results
2.4.1Cloning of GRASP, a tRA-induced gene
Subtractive hybridization was used to identify tRA-inducedgenes in P19 EC
cells grown in monolayers. A 2.1 kb transcript, referredto hereafter as GRASP, was
shown to be induced by tRA in a dose-dependentmanner by northern analysis of P19
cells grown in monolayer culture (Fig. 2.1A, middle panel). Asa control, the blot was
also probed for RARI3, a gene known to be strongly induced by RA in P19cells (Song
and Siu 1989) and for 36B4, which encodes the acidic ribosomal phosphoproteinP0, a
highly expressed "housekeeping" gene (Krowczynska, Couttset al. 1989) that is
unresponsive to tRA treatment.2.4.2Induction of GRASP in the presence of cycloheximide
In order to determine if induction of GRASP occurred independently of protein
synthesis, mRNA was isolated from P19 cells treated with 1.0 .tM tRA in thepresence
and absence of cycloheximide (10 jig/mi; (Obrig, Cuip et al. 1971), and analyzedby
northern blotting. GRASP mRNA levels in P19 cellswere increased by cycloheximicle
treatment (Fig. 2. lB, middle panel, lane 3) and this was further augmented by treatment
with tRA (compare lanes 3 and 4 of Fig. 2. lB), suggesting thatat least part of the
induction of GRASP expression by tRA in P19 cells didnot require protein synthesis.
Induction of RARI3 by tRA was not attenuated by cycloheximidetreatment under these
conditions (Fig. 2.1B, top panel).
2.4.3Time course of tRA-induced expression of GRASP in P19 cells
Northern analyses were performed to determine the timecourse of tRA
induction of GRASP in P19 cells grown in monolayer andaggregate cultures, as
induction of P19 cell differentiation by tRA under these two conditions results in
markedly distinct phenotypes (Jones-Villeneuve, McBurney et al. 1982; Roguska and
Gudas 1985). Induction of GRASP was observed within 2 hrs. of initiation of tRA
treatment in both monolayer and aggregate cultures (compare lanes 1 and 2 with lanes 6
and 7 of Fig. 2.lC, middle panel). Growth of P19 cells in aggregates resulted ina47
higher basal expression of GRASP (2-fold induction) relative to cellsgrown in
monolayer culture (compare lanes 1 and 6 of Fig. 2.1 C, middle panel) whereas there
was no difference in basal RAR3 levels when comparing monolayer and aggregate
cultures (lanes 1 and 6, respectively, of Fig. 2.1C, top panel). GRASP transcripts
increased gradually following tRA treatment of P19 cells grown ina monolayer,
reaching a maximum of 18-fold induction at 24 hrs. (Fig. 2.1C, lanes 1-4, middle
panel).In contrast, tRA induction of RAR3 expression in P19 cellsgrown in
monolayers reached maximal levels at 8 hrs. (56-fold induction) and further induction
of this gene was not observed over the remainder of this experiment (Fig. 2. 1C, top
panel). GRASP and RARI3 exhibited similar induction patterns of tRA inducibility in
P19 cells grown in aggregate culture with the corresponding mRNA levels continuing to
increase during the entire 48 hrs. of RA treatment (Fig. 2.1C, lanes 6-10).Thus,
although RARf3 and GRASP both appear to be direct targets of tRA in P19 EC cells, the
pattern of inducibility of these two genes is subtly distinct suggesting that additional
regulatory mechanisms may exist for one or both genes.
2.4.4GRASP contains multiple sites for protein-protein interactions
The GRASP fragment isolated by subtractive screening was used to isolate a
full-length clone from a randomly primed mouse embryo cDNA library. The 1,978 bpGRASP clone obtained contained anopen reading frame (ORF) encoding a 392 amino
acid protein with a predicted molecularmass of 42,382 Da. This ORF is preceded by a
single, in-frame stop codon (nucleotides 35-37) and is followedby a polyadenylation-
like motif (nucleotides 1944-1949, Fig. 2.2A). In addition, the 3'untranslated region of
the GRASP transcript contains an AU-rich cluster (nucleotides1264-1276) similar to
those found in and proposed to account for thevery low level expression of many
immediate-early genes (Shaw and Kamen 1986; Jones and Cole 1987; Kabnickand
Housman 1988; Wilson and Treisman 1988; Shyu, Belascoet al. 1991).
A database search revealed that GRASP isa novel gene that displayed very little
overall similarity with known sequences. However, analysis of the predicted amino
acid sequence revealed that GRASP contains several known protein-protein interaction
motifs (see Figs. 2.2A and B), including: (1)a putative SH3 domain binding site
(PXXP) within an alanine-/proline-rich region (Feng, Chenet al. 1994), (2) a PDZ
domain (see below and Fig. 2.2B; (Kennedy 1995), and (3)a leucine-rich region
predicted to be a-helical in nature (data not shown). Amino acid alignment of the PDZ
domain of GRASP with those of various other proteins (Fig. 2.2B) revealed that
GRASP exhibited substantial similarity to members of the MAGUK family of proteins
(Woods and Bryant 1991; Cho, Hunt et al. 1992; Itoh, Nagafuchi et al. 1993; Kim, Cho50
et al. 1996; Muller, Kistner et al. 1996) and to the regulator of G-protein signaling
RGS12 (Snow, Antonio et al. 1997).
2.4.5Distribution of GRASP in mouse tissues
RT-PCR analyses revealed that GRASP was very highly expressed in brain
relative to the other tissues examined, but expressionwas also detected in lung and
heart, and to a lesser extent in embryo (10-12.5 days post coitum), kidney andovary
(Fig. 2.2C). Expression of GRASP was not observed in thymus, spleen, liveror testis.
2.4.6 Subcellular localization of GRASP in HEK293 cells
To study the subcellular localization of GRASP in mammalian cells and
sequence determinants thereof, constructs encoding Myc epitope-tagged full-length and
deletion mutants of GRASP were used to transfect HEK293 cells transiently and the
fusion proteins were visualized by indirect immunofluorescence and confocal
microscopy.Although GRASP does not harbor predicted membrane-spanning
domains, both Myc-GRASP and Myc-GRASP 1-186 appeared to be localized to the
plasma membrane (Figs. 2.3A and B) in addition to some diffuse cytosolic staining. In
contrast, Myc-GRASP 189-392, which lacks the amino terminal alanine-/proline-rich
region and the PDZ domain, was not localized to the plasma membrane but rather was51
associated with large vesicular structures that were distributed diffusely throughout the
cytoplasm (Fig. 2.3C). These results suggest that full-length GRASP is associated with
the plasma membrane of transiently transfected HEK293 cells and that the amino
terminal alanine-/proline-rich region and/or PDZ domain are responsible for this
localization.
2.4.7Isolation of GRP1 as an interaction partner of GRASP
The presence of putative protein-protein interaction motifs and the lack of any
known catalytic domains suggested that GRASP may function as an adaptor protein.
Toward the goal of elucidating the function of this novel protein, we employed a yeast
two-hybrid system (Le Douarin, Pierrat et al. 1995; Avram, Ishmael et al. 1999; Dowel!,
Ishmael et al. 1999) to isolate proteins expressed in the mouse embryo that may interact
with GRASP subdomains. From a screen using the leucine-rich region of GRASP
(amino acids 180-257) as a bait, a clone was isolated that encoded amino acids 1-156 of
GRP1. The leucine rich region of GRASP was observed to interact strongly and
specifically with GRP1 1-156 in yeast (Fig. 2.4A).
In order to confirm the interactions of GRASP and GRP1 that we observed in
yeast, in vitro GST pull-down experiments were performed. GRP1 exhibited a strong
interaction with both GST-GRASP and GST-GRASP 1-257 (Figs. 2.4B and C, lanes 352
Figure 2.2. Nucleotide and predicted amino acid sequence and tissue distribution of
GRASP transcripts. (A) Nucleotide and predicted protein sequence of GRASP.
Numbers in margins correspond to the nucleotide and amino acid positions.The
following features are indicated by a box in the sequence: (1) an in-frame stop codon
preceding the GRASP open reading frame (nucleotides 35-37), (2) an alanine- and
proline-rich region (amino acids 15-71) containing a putative SH3 domain binding site
(PGAP; amino acids 47-50), (3) a PDZ domain (amino acids 96-186, see alsoB),(4) a
leucine-rich region (amino acids 196-262), (5) an AU-rich sequence (nucleotides 1264-
1279), (6) and a polyadenylation signal (nucleotides 1944-1959).(B)Alignment of the
PDZ domain of GRASP with PDZ domains from other proteins. Amino acid identities
and conserved substitutions are indicated by shaded boxes. Arrows are positioned over
residues implicated in peptide binding by some PDZ domain-containing proteins. The
sequences are as follows: GRASP, amino acids 96-186; lethal(1)discs-large (DLG), third
PDZ domain, amino acids 482-564; SAP1O2, third PDZ domain, amino acids 400-482;
CHAPSYN1 10, third PDZ domain, amino acids 417-499; PSD95, third PDZ domain,
amino acids 309-391; ZO-1, amino acids 19-107; RGS12, amino acids 17-95. This
alignment was performed using ClustaiW 1.7. (C) Expression of GRASP in the embryo
and various adult mouse tissues. RT-PCR and Southern analysis were performed as
described in Materials and Methods. Shown in C is a representative experiment that
was replicated three times.54
and 4), but not with GST-GRASP 1-186, GST-GRASP 1-82,or GST alone (lanes 5, 6,
and 2, respectively). These results demonstrate that the amino acid residuessufficient
for interaction with GRP1 are contained within the leucine-richregion of GRASP
(residues 180-257) and that full-length GRASP is capable ofstrong interaction with
GRP1 in vitro.
2.4.8Residues in the N-terminal region of GRP1 mediate the interaction
with GRASP
In order to determine the region of GRP1 responsible for mediating interaction
with GRASP, in vitro protein-protein interactionassays were carried out using GST-
GRASP and truncation mutants of GRP1 (Fig. 2.5A). Full-length GRP1 (Fig. 2.5B,
lane 3) and GRP1 1-95 (lane 9) exhibiteda strong interaction with GST-GRASP, but
neither protein interacted with GST alone (lanes 2 and 8, respectively). GRP1 1-95
contains a coiled-coil domain (residues 18-59) anda small fragment of the Sec7 domain
(residues 72-95; see Fig. 2.5A).In contrast, GRP1 72-399, which lacks the amino
terminal coiled-coil domain but contains the entirety of both the Sec7 and PH domains,
failed to interact with GST-GRASP (Fig. 2.5B, lane 6), confirming that the latter
domains of GRP 1 are not required for interaction with GRASP. Because cytohesin-2 is
also expressed in P19 cells (see below) and the amino terminal coiled-coil region of
GRP1 and cytohesin-2 share considerable identity (see Fig. 2.5C),we next determined56
if GRASP and cytohesin-2 interact in vitro. Cytohesin-2 1-93 whichcontains the amino
terminal coiled-coil region (see Fig. 2.5C), like GRP1 1-95 exhibiteda strong
interaction with GST-GRASP, but not GST alone (Fig. 2.5B lanes 12and 11,
respectively). These findings demonstrate that the amino terminal regions ofboth
GRP1 and cytohesin-2 are sufficient to mediate interaction with GRASP.
2.4.9BFA-insensitive ARF GEFs are differentially expressed in P19 cells
Because GRASP and GRP1 interacted strongly in yeast and in vitro,we next
sought to determine if GRP1 and the other closely related members of this subfamily,
cytohesin-2 and cytohesin-1, are coexpressed with GRASP during RA-induced
differentiation of P19 EC cells, whichmay facilitate a physiologically relevant
interaction. RT-PCR and Southern blottingwere employed to determine the relative
expression of these transcripts in vehicle- and tRA- (1.0 pM, 24 hrs.) treated P19 cells.
Expression of cytohesin-1 was not detected in either untreatedor tRA-treated P19 EC
cells whereas cytohesin-2 was highly expressed in both samples (Fig. 2.5D, lanes1 and
2 and lanes 3 and 4, respectively). GRP1 expressionwas also detected in P19 cells
(Fig. 2.5D, lanes 5 and 6). Neither cytohesin-2nor GRP1 expression appeared to be
responsive to tRA treatment of P19 cells (Fig. 2.5D, lanes 3 and 4 and lanes 5 and 6,
respectively).57
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Figure 2.4. Interactions between GRP1 and GRASP. (A) Interactions
between GRP 1 and GRASP in yeast. A bait consisting of the LexA DBD
fused to GRASP 180-257 and a prey consisting of the VP16 activation
domain fused to GRP 11-156 were used to cotransform the L40 strain of S.
cerevisiae.3-galactosidase assays were performed in liquid yeast culture
as described in Materials and Methods.Each 3-galactosidase value
represents the mean ± standard error of 4-6 independent determinations.
(B) Schematic of the GST-GRASP fusion constructs used for in vitro
protein-protein interaction assays. (C) In vitro protein-protein interaction
between full-length GRP1 and GRASP truncation mutants. GST, GST-
GRASP or the corresponding deletion mutants of GRASP were bound to
glutathione sepharose and used as affinity matrices to examine interactions
with full-length, [35S]methionine-labeled GRP1. Shown is a gel from a
representative experiment that was replicated three times.2.4.10 Coimmunoprecipitation of GRASP and GRP1 from HEK293 cell
extracts
Coimmunoprecipitation analyses were performed using extracts of HEK293
cells transfected with expression vectors encoding both Myc-GRASP and GFP-GRP1to
determine if GRASP and GRP1 were capable of interaction ina cellular context. Myc-
GRASP was immunoprecipitated from whole cellextracts using an anti-Myc
monoclonal antibody and immunoprecipitates were then analyzed by immunoblotting
using a monoclonal antibody directed against GFP.The anti-Myc antibody
coimmunoprecipitated GFP-GRP 1 from cells transfected with Myc-GRASP and GFP-
GRP1 (Fig. 2.6, lane 6) and coimmunoprecipitation of GFP-GRP1was dependent on
the presence of Myc-GRASP (compare lanes 5 and 6). However, the anti-Myc antibody
did not coimmunoprecipitate GFP in control cells expressing both Myc-GRASP and
GFP (Fig. 2.6, lane 4).These results clearly demonstrate that GRP1 and GRASP
interact in extracts of transiently cotransfected mammalian cells.
2.4.11GRASP colocalizes with GRP1 at the plasma membrane
As we have shown that GRASP is associated with the plasma membrane of
transfected cells (Fig. 2.3A), we employed inimunofluorescence and laser-scanningconfocal microscopy to determine if GRASP colocalizesat the cell periphery with GFP-
tagged GRP1. In the absence of GFP-GRP1 expression, Myc-GRASPwas detected at
the cell periphery and plasma membrane of HEK293 cells (Fig.2.7A; see also Fig.
2.3A). Consistent with these data, Myc-GRASPwas found to be stably associated with
the membrane fraction of transiently transfected HEK293 cellsas detected by
immunoblot analysis (data not shown).
In the absence of Myc-GRASP expression, GFP-GRP1 displayeda diffuse
cellular staining that included substantial plasma membrane localizationas detected by
confocal microscopy (Fig. 2.7B). However, GFP-GRP1 didnot appear to be stably
associated with the membrane fraction as detected by immunoblot analysisof cell
fractions prepared from these cells (Fig. 2.7F). For example, the ratio of GFP-GRP1
immunoreactivity present in the cytosolicversus the membrane fraction was
approximately 10:1 (Fig. 2.7F, lanes 9-11). This finding, when considered with the
results of confocal microscopy, suggets that GRP1may be loosely associated with the
plasma membrane in the absence of Myc-GRASP expression.
Coexpression of Myc-GRASP and GFP-GRP1 and staining with the
corresponding antibodies revealed a precise overlap in the localization of thetwo
proteins at the plasma membrane of HEK 293 cells (Figs. 2.7C and D, respectively;see
also overlay, Fig. 2.7E). Moreover, coexpression of Myc-GRASP appearedto stabilize61
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Figure 2.6.Coimmunoprecipitation of GFP-GRP1 and
Myc-GRAS? from mammalian cell extracts. Whole cell
lysates from HEK 293 cells transfected with the indicated
expression vectors were immunoprecipitated usingan anti-
Myc monoclonal antibody.Immunoprecipitates were then
subjected to immunoblot analysis using an antibody directed
against GFP. Shown is a gel from a representative experi-
ment that was replicated twice. The immunoglobin heavy
(HC) and light (LC) chains are indicated.62
association of GFP-GRP1 with plasma membrane loci as indicated by immunoblotting.
In contrast to results obtained when GFP-GRP1 was expressed with increasing amounts
of an empty expression vector (Fig. 2.7F lanes 9-11;see also above), cotransfection
with increasing amounts of a Myc-GRASP altered the subcellular distribution of GFP-
GRP1 such that the cytoplasmic:membrane ratio of GFP-GRP1 immunoreactivity
approached or exceeded unity (Fig. 2.7F, lanes 12 and 13). The distribution of GFP
was unaffected by cotransfection with a Myc-GRASP expression vector (Fig. 2.7F,
compare lanes 4-6 with 7 and 8). Collectively, these results demonstrate an increased
association of GRP1 with plasma membrane loci in the presence of Myc-GRASP.
These findings also lend further support to the hypothesis that GRASP.GRP1
complexes exist in intact, transfected cells.
2.4.12GRASP colocalizes with ARFs at the plasma membrane
It is hypothesized that recruitment of ORP1 to the plasma membrane leads to its
association with and subsequent activation of ARF proteins (Klarlund, Rameh et al.
1998; Langille, Patki et al. 1999). To determine if GRASP localizes to cellular ARF
loci, HEK293 cells were transfected with Myc-GRASP and double-labeled with
affinity-purified, anti-GRASP antiserum and a monoclonal antibody that recognizes all
human ARF subtypes (1D9; kindly provided by Dr. Richard Kahn; Cavenagh, Whitney63
et al. 1996). In agreement with previous results, Myc-GRASP was found to associate
with the plasma membrane of transfected HEK293 cells and, to a lesser extent,was
diffusely distributed in the cytoplasm(Figs. 2.8B, B and H).Endogenous ARFs
appeared to be distributed mainly in the cytosol, however, staining was also apparent at
the plasma membrane (Figs. 2.8A, D and G). An overlay of the GRASP and ARF
confocal images reveals a precise colocalization of the two proteins at the plasma
membrane (Figs. 2.8C, F, and I).Interestingly, colocalization of ARFs and GRASP
was also observed in various surface protrusions of the plasma membrane (Figs. 2.81),
the formation of which have been observed upon activation of ARF6 (Radhakrishna,
Klausner et al. 1996). These results suggest that GRASP colocalizes with endogenous
ARFs and lends support to the hypothesis that GRASP may influence ARF signaling.
2.5Discussion
We report the molecular cloning of GRASP, a novel gene that isupregulated in
P19 EC cells treated with tRA. Induction of GRASP by tRA in P19 cells was not
completely inhibited by cycloheximide, suggesting that this gene may be a direct target
of tRA. However, induction of GRASP by tRA differed qualitatively and quantitatively
in P19 cells grown as monolayers versus areates suggesting that GRASP may be
subject to additional regulatory controls. GRASP is selectively expressed in a number65
of mouse tissues with the highest level of expression observed in brain, heart and lung.
GRASP transcripts were also detected in 10-12.5 day mouse embiyos.
Analysis of the coding sequence revealed that GRASP harbors multiple sites for
protein-protein interactions, which raises the possibility that GRASPmay function as an
adaptor or scaffolding protein. A search of the protein databases revealed that GRASP
displayed partial sequence similarity with clone B3-1, a gene that was originally
isolated from a Natural Killer (NK)/T cell subtracted library (Dixon, Sahely et al. 1993).
The regions of similarity include the PDZ domain, the leucine rich region, and residues
within the carboxyl terminal region (data not shown). Interestingly, B2-1 (Liu and
Pohajdak 1992), later referred to as cytohesin-1 (Kolanus, Nagel et al. 1996), was
cloned from the same subtracted NKIT cell library which, in light of the results
presented herein, raises the possibility that B3-1 and B2-1 may interact and coordinate
some NK cell functions. The function of B3-1 remains unknown, although Dixon and
colleagues (Dixon, Sahely et al. 1993) speculated that B3-1 may be a transcription
factor because of the presence of a leucine zipper domain and prevalence of negatively
charged residues. However, the results of indirect immunofluorescence and confocal
microscopy studies reported herein demonstrated that Myc-GRASP was excluded from
the nucleus and appeared to be localized at the plasma membrane. Because thereare no
predicted membrane spanning domains within its sequence, it seems likely that GRASP67
is a peripheral membrane protein. Localization of GRASPat the plasma membrane
appeared to be dictated by the amino terminal region of the protein which harborsboth
the alanine-/proline-rich region and the PDZ domain. A deletionmutant that lacks the
alanine-/proline-rich region and PDZ domain, Myc-GRASP 189-392,was observed to
be associated with large vesicular structures located diffusely throughout thecell.It is
not known whether Myc-GRASP 189-392 associates with these structures simplyas a
result of mislocalization, or whether these structures ariseas a result of Myc-GRASP
189-392 expression, which would suggest a dominant inhibitory effect. Amore
thorough analysis of the nature of these vesicles will be requiredto clarify this issue.
Nevertheless, our data clearly implicate amino terminal residues, including the alanine-
/proline-rich region and PDZ domain, as important determinants of GRASP subcellular
localization. These results are consistent with reports that PDZ domains playa role in
the proper cellular localization of many proteins (Ponting, Phillips et al. 1997).
It has been proposed that the PDZ domains of several proteins facilitate
synaptic neurotransmission by physically linking variouscomponents of a signal
transduction cascade at specific, subcellular loci (Kornau, Schenkeret al. 1995;
Gomperts 1996; Kim, Cho et al. 1996; Niethammer, Kim et al. 1996). For example,
maD contains five PDZ domains each of which bindsa specific protein component in
the Drosophila phototransduction signaling pathway facilitating their juxtaposition andenhancing the efficiency and specificity of signal transmission (Tsunoda,Sierralta et al.
1997). The possibility that GRASPmay perform a similar cellular function within the
Context of ARF signaling pathways is suggested by the present findings but this remains
to be established.
Members of the cytohesin subfamily of ARF GEFscan be recruited to the
plasma membrane of cells in response to growth factor stimulation (Nagel,Zeitlmann et
al. 1998; Venkateswarlu, Gunn-Moore et al. 1998; Venkateswarlu, Oateyet al. 1998).
Activation of many growth factor receptors at the cell surface results instimulation of
PT 3-kinase, and subsequent phosphorylation of the D3 positionon phosphatidylinositol
and its phosphorylated derivatives (Hawkins, Jackson et al. 1992). Generationof 3'-
phosphorylated derivatives, specifically phosphatidylinositol (3 ,4,5)-trisphosphate, is
thought to promote the association of cytohesin subfamily members with membranes
through interaction of phosphatidylinositol (3,4,5)-trisphosphate with the GEF PH
domain (Nagel, Schilcher et al. 1998; Venkateswarlu, Gunn-Mooreet al. 1998;
Venkateswarlu, Oatey et al. 1998).Conversely, inhibitors of PT 3-kinase, such as
wortmannin, have been shown to block translocation of these proteinsto the plasma
membrane, resulting in cytosolic localization (Venkateswarlu, Gunn-Mooreet al. 1998;
Venkateswarlu, Oatey et al. 1998). It is thought that recruitment of these proteinsto the
membrane creates a favorable interface for the interaction of GEF and ARF proteins,leading to stimulation of GDP/GTP exchange and subsequent activation of ARFs
(Chardin, Paris et al. 1996; Frank, Upender et al. 1998; Kiarlund, Rameh et al. 1998;
Langille, Patki et al. 1999). This is supported by in vitro experiments that demonstrated
enhanced GEF stimulated GTPyS binding by various myristoylated ARFs in the
presence of lipid vesicles and phosphorylated derivatives of phosphatidylinositol
(Chardin, Paris et al. 1996; Frank, Upender et al. 1998; Klarlund, Rameh et al. 1998;
Langille, Patki et al. 1999). Enhanced GDP/GTP exchangewas completely abolished
by addition of the inositol headgroup moiety, inositol 1 ,3,4,5-tetrakisphosphate,to the
reaction, indicating that enhanced GEF activity results from its association with
membranes and not an allosteric change that promoted its catalytic activity (Kiarlund,
Rameh et al. 1998). Taken together, these results are consistent witha model that
binding of phosphatidylinositol (3,4,5)-trisphosphate to the PH domain ofa particular
GEF results in the translocation of that GEF to the plasma membrane, at which the
protein is able to promote GDP/GTP exchange on ARF proteins.
The results of the present study identify GRASP as a novel interaction partner
for GRP1 and suggest that cellular localization of ORPI may be influenced by the
interaction of the GRP1 coiled-coil domain with GRASP. Similar results have been
obtained by Neeb and coworkers who demonstrated an interaction of the coiled-coil
region of msec7-1, the rat homologue of cytohesin-1, and the presynaptic protein70
Muncl3-1, which serves to target msec7-1 to the activezone at the presynapse (Neeb,
Koch et al. 1999). It may be speculated that thepresence of a PDZ domain in GRASP
could allow the selective subcellular targeting of GRP1or cytohesin-2 to discrete
plasma membrane domains, resulting in subsequent activation of distinct ARFs. This is
an attractive possibility that could result in the juxtaposition of GEF(s) and components
of specific signaling pathways. Other motifs present in GRASP could also facilitate
interactions with possible downstream effectors, implicating GRASPas a putative
scaffold protein. A parallel example of this type of subcellular targetingmay exist in
the Rho family of GTPases. Tiami, a GEF for Raci (Habets, Scholtes et al. 1994;
Michiels, Habets et al. 1995), has been implicated in regulating neuronal morphology
(Leeuwen, Kain et al. 1997). In addition to a PH and a Dbl homology domain, Tiami
contains a PDZ domain (Habets, Scholtes et al. 1994) that may target this GEF toa
particular subcellular locus thus facilitating specificity in mediating Rac 1-induced
events.
Interaction of GRP1 with GRASP or GRASP-like proteins may also be
speculated to promote adhesion of the ctLI32 integrin (LFA- 1) to its extracellular ligand,
ICAM-1.Kolanus and coworkers (Kolanus, Nagel et al. 1996) have shown that
cytohesin- 1 interacts with carboxyl terminal residues of the2 integrin receptor subunit,
increasing the avidity of LFA- 1for ICAM- 1.Because of the strong sequence71
similarity, it seems likely that other members of the cytohesin subfamilymay be able to
function in this capacity.If GRASP, or a GRASP-like protein, acting through its
alanine-/proline-rich region and/or PDZ domain, associates with integrinreceptors
and/or associated proteins, it is conceivable that recruitment of cytohesinfamily
members to this locus may similarly enhance the avidity of LFA- 1 for ICAM-1. Such
speculation would be consistent with previous studies demonstrating thattreatment of
various cell types with RA results in modulation of integrin adhesion(Dedhar,
Robertson et al. 1991; Rossino, Defilippi et al. 1991; Elias, Chammaset al. 1994;
Gaetano, Meichiori et al. 1994; Loeser 1994; Ross, Ahrenset al. 1994). For example,
Katagiri and coworkers have shown that retinoic acid potentiates cellular adhesionand
aggregation mediated by LFA-1 and ICAM-1 in HL-60 cells undergoing neutrophilic
differentiation (Katagiri, Kinashi et al. 1996). This alteration in cellular adhesiveness
does not result from increased levels of expression of either LFA- 1or ICAM- 1, but
rather is induced by a change in the avidity state of LFA- 1 (Katagiri, Kinashiet al.
1996). This change in LFA-1 avidity was shown to require denovo protein synthesis
and to occur within 24 hrs. of initiation of RA treatment (Katagiri, Kinashiet al. 1996),
consistent with the time course of maximal induction of GRASP mRNA in P19 cells
reported herein.72
In summary, RA-induced expression of GRASPmay represent a point of
convergence between the nuclear receptor signaling pathways and activation of plasma
membrane-associated ARF proteins.Induction of GRASP by RA may influence
cellular phenotypy via one or more of the multiple pathways described above thatmay
underlie, at least in part, the pleiotropic effects of RA during cellular differentiation
andlor in cellular function.
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Overexpression of GRASP Results in a Disruption of the ARF6-Mediated Plasma
Membrane Recycling Pathway
Daniel J. Nevrivy Valerie J. Peterson, Marcia I. Dawson, and Mark Leid
Program in Molecular and Cellular Biology
and laboratory of Molecular Pharmacology, College of Pharmacy
Oregon State University
Corvallis, OR 973313.1Abstract
GRASP is a retinoic acid-induced gene product from P19 embryonal carcinoma
cells that we have previously shown interacts with the ADP-ribosylation factor 6
(ARF6) guanine nucleotide exchange factors general receptor for phosphoinositides 1
(GRP 1) and cytohesin-2. ARF6, a member of the Ras superfamily of low molecular
weight GTPases, regulates key aspects of endocytic recycling pathways. Here we
demonstrate that overexpression of GRASP leads to the accumulation of GRASP in the
endosomal compartment where GTP-binding deficient mutants of ARF6 reside,
suggesting that GRASP may induce a block in an ARF6 recycling pathway.
Coexpression of GRP1, but not a catalytically inactive mutant dramatically reduced the
accumulation of GRASP in this compartment. Furthermore, GRP1 mutants that lacked
the region of interaction with GRASP failed to prevent the accumulation of GRASP in
the endosomal compartment, suggesting that GRASP recruits GRP1 to the endosomal
compartment where GRP1 stimulates nucleotide exchange of ARF6 and recycling. We
show that residues within amino acids 180-257 of GRASP are necessary and sufficient
to induce the accumulation of GRASP in the endosomal compartment. We identify
residues within this region of GRASP that are required for efficient interaction with
GRP1 and also dictate GRASP localization to actin-based structures at the cell
periphery, suggesting that GRASP may enter the recycling pathway at these sites
through recruitment of GRP1 and ARF6.3.2Introduction
ADP ribosylation factors (ARFs) are small GTPases of the Ras superfamily that
regulate key aspects of membrane traffic in cells (Moss and Vaughan 1998). ARF
proteins were originally identified as cofactors of the cholera toxin-catalyzed ADP-
ribosylation of G a and have also been shown to be activators of phospholipase D
(Brown, Gutowski et al. 1993). ARF proteins are divided into three classes based on
phylogenetic analysis and size. The class I ARFs, which include ARFs 1-3, are the best
characterized and function in vesicular trafficking pathways in the Golgi apparatus
(Serafini, Orci et al. 1991; Balch, Kahn et al. 1992), while little is known about the
function of class II ARFs (ARFs 4-5). ARF6, the least conserved member of the
family, comprises class III and regulates endocytic and actin remodeling pathways
(D'Souza-Schorey, Li et al. 1995; Radhakrishna and Donaldson 1997).
ARF proteins cycle between inactive GDP and active GTP-bound
conformations. The alternative conformations of ARFs, induced by GTP-binding and
subsequent hydrolysis of the bound nucleotide to GDP, facilitate interaction with, and
activation of various classes of effector proteins. As ARF proteins are poorly able to
exchange GDP and hydrolyze GTP on their own, these reactions are catalyzed by
GTPase activating proteins (GAPs) and guanine nucleotide exchange factors (GEFs),
respectively. An increasing number of proteins exhibiting ARF GAP activity have been
described (Donaldson 2000). Interestingly, many of these proteins harbor well defineds'sJ
signaling motifs, such as ankyrin repeats, PH, proline-rich and SH3 domains, which
may link the ARF cycle to various signal transduction pathways. ARF GEFs, which all
share a conserved catalytic domain of approximately 200 amino acids that is
homologous to yeast Sec7 protein, fall into two categories based on size and sensitivity
to inhibition by brefeldin A (BFA), a toxic fungal metabolite that blocks protein
secretion and Golgi function. Members of the cytohesin family of proteins comprise the
low molecular weight BFA-insensitive ARF GEF category. The cytohesin family
includes cytohesin-1 (also known as B2-l; (Liu and Pohajdak 1992; Kolanus, Nagel et
al. 1996), ARNO (ARF nucleotide-binding site Qpener; also known as cytohesin-2;
(Chardin, Paris et al. 1996), GRP1 (Kiarlund, Guilherme et al. 1997), and cytohesin-4
(Ogasawara, Kim et al. 2000).The cytohesins share a common domain structure
consisting of an amino-terminal coiled-coil domain, followed by a Sec7 domain that is
responsible for GEF activity, a pleckstrin homology (PH) domain that binds
phosphoinositides and aids in membrane recruitment, and a polybasic region at the
carboxyl terminus. Several laboratories have demonstrated a phosphatidylinositol 3-
kinase-dependent translocation of cytohesins to the plasma membrane of cells (Clodi,
Vollenweider et al. 1998; Nagel, Zeitlmann et al. 1998; Venkateswarlu, Gunn-Moore et
al. 1998; Venkateswarlu, Oatey et al. 1998; Langille, Patki et al. 1999; Venkateswarlu,
Gunn-Moore etal.1999; Klarlund, Holik etal.2001), however the cellularconsequences of 3'-phosphoinositide generation as it relates to the ARF cycle is
relatively unexplored.
Early studies that demonstrated cytohesins exhibited GEF activityon ARF1
(Paris, Beraud-Dufour et al. 1997), coupled with studies in transfected cells which
showed that overexpression of ARNO and ARNO3 (GRP1) resulted ina disassembly of
the Golgi complex (Franco, Boretto et al. 1998; Monier, Chardin et al. 1998), led to the
conclusion that cytohesins function on class I ARFs. In addition to their possible role in
regulating ARF1 function, recent studies have shown that cytohesinsare able to activate
ARF6 in vitro (Frank, Upender et al. 1998; Knorr, Nagel et aJ. 2000), in cultured cells
(Langille, Patki et al. 1999), and colocalize with ARF6 in plasma membrane ruffles
(Frank, Upender et al. 1998; Langille, Patki et al. 1999). In further support for the role
of cytohesins as ARF6 GEFs, Caumont and coworkers have shown that ARNO
activates secretion in chromaffin cells in an ARF6-dependent manner (Caumont, Vitale
et al. 2000), while Mukherjee et al have shown that the ARF6-dependent beta-arrestin
release necessary for luteinizing hormone/choriogonadotropin receptor desensitization
requires ARNO catalytic activity (Mukherjee, Casanova et al. 2001).
Overexpression analyses of GTP binding-defective (dominant negative, GDP-
bound) and GTPase deficient (constitutively active, GTP-bound) ARF6 mutants in cells
have greatly contributed towards the functional elucidation of the ARF6 cycle
(D'Souza-Schorey, Li et al. 1995). D'Souza-Schorey and coworkers discovered a rolefor ARF6 in receptor-mediated endocytosis by analyzing transferrin receptor recycling
in TRVb-1 cells expressing ARF6 mutants (DSouza-Schorey, Li et al. 1995). They
showed that in cells expressing a GTPase-deficient mutant of ARF6, ARF6 Q67L,
transferrin receptors were localized exclusively to the plasma membrane along with
ARF6 Q67L and cells exhibited increased transferrin cell surface binding (D'Souza-
Schorey, Li et al. 1995). In contrast, cells expressing a GTP-binding deficient mutant of
ARF6, ARF6 T27N, exhibited a block in plasma membrane recyclingas transferrin
receptors were internalized on endosomes with the ARF6 mutant, leading to a reduction
in transferrin cell surface-binding (D'Souza-Schorey, Li et al. 1995). Studies in HeLa
cells, however, revealed that ARF6 cycles between the plasma membrane and a
recycling compartment that is distinct from the transferrin receptor recycling
compartment, indicating heterogeneity in these compartments depending on the cell
type (Radhakrishna and Donaldson 1997). In addition, Peters et al demonstrated that
overexpression of these ARF6 mutants in cells resulted in profound changes of the
peripheral membrane system (Peters, Hsu et al. 1995). Expression of ARF6 Q67L
resulted in localization of the protein to plasma membrane invaginations and protrusive
structures, whereas ARF6 T27N expression resulted in the massive accumulation of
large aggregates of tubulovesciular structures where the mutant resided (Peters, Hsu et
al. 1995). These results have led to the hypothesis that nucleotide exchange on ARF6
occurs on recycling endosomes, resulting in translocation and fusion of the endosomeswith the plasma membrane (D'Souza-Schorey, Li et al. 1995; Peters, Hsuet al. 1995;
D'Souza-Schorey, van Donselaar et al. 1998). To complete the cycle, GTP hydrolysis
of ARF6 at the plasma membrane appears to be required for ARF6to become
internalized and localize in the endosomal compartment.
Despite evidence suggesting that nucleotide exchange of ARF6occurs on
endosomes, there are limited studies linking GEF function to ARF6-mediated
endosomal recycling. Franco and coworkers demonstrated that overexpression of the
ARF6 GEF, EFA6, in TRVb-1 cells resulted in a redistribution of transferrin receptors
from intracellular vesicles to the plasma membrane (Franco, Peters et al. 1999), whereas
overexpression of ARNO3, the human homolog of GRP1, hadno effect on the
distribution of transferrin receptors.Additionally, Maranda et a! have shown that
ARNO and ARF6 are recruited to endosomes in kidney proximal tubule endothelial
cells in a pH- dependent manner (Maranda, Brown et al. 2001).
Recent work in this laboratory identified GRASP, a novel retinoic acid-induced
gene product that interacts with the cytohesin family members GRPI and cytohesin-2
(Nevrivy, Peterson et al. 2000). Here we report that the localization of overexpressed
GRASP in HEK293 cells mimics the endosomal localization of ARF6 GTP-binding
deficient mutants, that is indicative of a block in a plasma membrane recycling
pathway. Coexpression of ARF6 N 1221, a GTP-binding defective mutant, increased the
extent of GRASP localization in the endosomal compartment.Interestingly,coexpression of GRP1 dramatically reduced the accumulation of GRASP in the
endosomal compartment, whereas coexpression of a catalytically inactive mutant of
GRP1 did not. In addition to a functional Sec7 domain, the presence of the coiled-coil
domain of GRP1 was required to prevent GRASP localization in the endosomal
compartment, suggesting that GRASP recruits GRP1 to endosomes where GRP1
stimulates guanine nucleotide exchange on ARF6.
3.3Materials and Methods
3.3.1Cell Culture and Transfections
Human embryonic kidney (HEK) 293 cells were maintained as described
reviously (Nevrivy, Peterson et al. 2000). Transfections were carried out as described
previously (Nevrivy, Peterson et al. 2000) in 6-well plates using 0.5 pg of each
expression vector (1.0 jig total) for fluorescence microscopy studies or in 100-mm
plates using 3.0 .tg of each expression vector (6.0 jig total) for coimmunoprecipitation
analyses.3.3.2Plasmid Constructs
ARF6 expression vectors were kindly provided by Dr. K. Nakayama (Toda,
Nogami et al. 1999). The GRP1 construct was kindly provided by Drs. Michael Czech
and Jes Kiarlund (Kiarlund, Guilherme et al. 1997). All constructs were prepared using
standard techniques. Supplemental details are available upon request.
3.3.3Fluorescence Microscopy
Twenty-four hours following transfection, HEK293 cells growing on coverslips
were fixed in 4% paraformaldehyde and permeabilized in two changes of PBS + 0.02%
Triton-X- 100. Antibody incubations were performed using standard techniques with
the anti-Myc monoclonal antibody (Invitrogen), anti-HA polyclonal antibody (Santa,
Cruz), or anti-GRP1 polyclonal antibody (Santa Cruz). Images were captured on a
Leica fluorescence microscope using Openlab software (Improvision) and processed
using Photoshop 5.0 (Adobe Systems, Inc.). For GRASP endosomal scoring assays, a
minimum of 50 cells were counted and scored for the accumulation of endosomes that
stained positively for GRASP. Only cells that exhibited a large accumulation of
GRASP in the endosomal compartment were scored as positive.3.3.4Coimmunoprecipitation Analyses
For coimmunoprecipitation analysis, transfected HEK293 cells were collected in
solubilization buffer (10 mM Hepes pH 7.4, 150 mM NaCJ, 1mM EDTA, 1 mM DTT,
10% (vlv) glycerol, 0.1 mM PMSF, 10 p.M pepstatin A, 10 p.M leupeptin, 25 p.g/ml
aprotinin, 0.05% (v/v) NP-40 and 0.5% (v/v) Triton-X-100) and incubated at 4°C with
rotation for 30 mm. The lysate was cleared by centrifugation at 16,000x g for 20 mm.
at 4°C. Three hundred micrograms of lysate protein was incubated with the anti-GFP
antibody (Research Diagnostics, Inc.) in a volume of 0.5 mL for 2 hr. at 4°C, after
which Protein A-Sepharose (100 pL, 50 mg/mi in solubilization buffer; Pharmacia) was
added and the incubation was continued at 4°C with rotation for an additional 60 mm.
The beads were collected by centrifugation (800 xg for 1 mm. at 4°C) and subsequently
washed gently four times with 1.0 mL solubilization buffer. Immunoprecipitates were
subjected to immunoblot analysis using goat anti-GRP1 antibody (Santa Cruz).
3.3.5GST Pull-down Experiments
GST fusion proteins were produced, crude bacterial lysates were prepared, and
GST pull-down experiments were conducted as described previously (Nevrivy, Peterson
et al. 2000).93
3.4Results
3.4.1 GRASP colocalizes with a GTP-binding deficient mutant of ARF6
We previously reported that GRASP localized predominantly to the plasma
membrane of transfected F1EK293 cells (Nevrivy, Peterson et al. 2000). In addition, we
have consistently observed GRASP staining in punctate, perinuclear structures that
appeared to be vesicular in origin (Fig. 3. 1A). This pattern of GRASP staining, which
has been observed in approximately 20% of transfected cells across a number of
experiments, resembles the endosomal staining pattern of cells expressing GTP-binding
deficient mutants of ARF6, ARF6 T27N and ARF6 N 1221, that induce a block in
plasma membrane recycling (D'Souza-Schorey, Li et al. 1995; Toda, Nogami et al.
1999). Thus, we have investigated the possibility that GRASP and ARF6 may function
in identical or related endosomal pathways of plasma membrane recycling.
To determine if wild-type GRASP localized in the same endosomal
compartment as ARF6 N1221, HEK293 cells were transiently cotransfected with
constructs encoding both proteins.These cells were subjected to indirect
immunofluorescence microscopy to define the subcellular localization of each protein.
Again, we found that GRASP staining was localized to punctate, cytoplasmic structures
in transfected cells (Fig. 3.1B) and this staining was coincident with that of ARF6N1221 (Fig. 3.1C, D). As ARF6 N1221 has been previously demonstrated to localize in
an endosomal compartment and induce a block in plasma membrane recycling (Toda,
Nogami et al. 1999), we conclude that the punctate, cytoplasmic structures stained by
the GRASP antibody correspond to one or more endosomal compartment(s). Moreover,
our data suggest that in a manner similar to that of ARF6 N1221, overexpression of
GRASP may induce a block in a plasma membrane recycling pathway.
3.4.2Coexpression of wild-type or constitutively active ARF6 does not affect
GRASP localization in the endosomal compartment
Our results demonstrating colocalization of GRASP with ARF6 N 1221 suggest a
possible involvement of GRASP in an ARF6 plasma membrane recycling pathway. To
investigate this possibility further, we determined the effect of expression of wild-type
or constitutively active ARF6, as well as ARF6 N1221, on the endosomal localization of
GRASP. Neither wild-type nor constitutively active ARF6, ARF6 Q67L, affected the
endosomal localization of GRASP, as 18% and 22% of cotransfected cells exhibited
GRASP endosomal staining, respectively, compared with 20% of cells transfected with
GRASP alone (Figs. 3.2A-C and D-F, see also Fig. 3.2J). In addition, wild-type ARF6
(Fig. 3.2B) and ARF6 Q67L (Fig. 3.2E) did not colocalize with GRASP in the
endosomal compartment, however, substantial colocalization of GRASP with both
proteins was observed at the plasma membrane of cells in which GRASP staining wasnot observed in the endosomal compartment (data not shown).In contrast,
coexpression of ARF6 N 1221 resulted in a dramatic increase in the fraction of cells with
an accumulation of GRASP-positive endosomes (52%; Figs. 3.2G-I and J). Moreover,
ARF6 N1221 and GRASP staining was found to be coincident in the endosomal
compartment of these cells (Fig. 3.21). In cotransfected cells that did not exhibit a block
in plasma membrane recycling, both GRASP and ARF6 N1221 staining appeared
diffusely distributed in the cytoplasm andlor at the plasma membrane (data not shown).
These results suggest that overexpression of GRASP, like that of ARF6 N1221,may
induce a block at one or more of the endosomal intermediates in a plasma membrane
recycling pathway.
3.4.3 High expression levels of wild-type GRASP contribute to GRASP
localization in the endosomal compartment
We hypothesized that the possible block in plasma membrane recycling that was
observed in a subpopulation of GRASP-transfected cells may be due to overexpression
of the protein. To test this hypothesis, HEK293 cells were transfected with increasing
amounts of an expression vector encoding GRASP followed by indirect
immunofluorescence microscopy.The percentage of cells that exhibited an
accumulation of endosomes staining positively for GRASP increased from 20 to 42%
with increasing amounts of transfected GRASP expression vector (Fig. 3.3), suggestingFigure 3.2. Expression of a GTP-binding deficientmutant ARF6, but not wild-type
or a constitutively active mutant of ARF6 enhances localization of GRASP in the
endosomal compartment. HEK293 cellswere transiently cotransfected with a
combination of expression vectors encoding Myc-GRASP andeither ARF6-HA (A-C),
ARF6 Q67L-HA(D-F),or ARF6 N1221-HA(G-J),followed by indirect
iinmunofluorescence microscopy as described in the legend of Figure1 and scoring of
transfected cells for the presence of GRASP endosomal localization.Cotransfected
cells shown in A, D, andGare representative cells stained with the Myc antibody that
indicate Myc-GRASP fluorescence while those shown inB, E,and H correspond to
cells stained with the HA antibody which represent ARF6-HA, ARF6Q67L-HA, and
ARF6 N 1221-HA fluorescence, respectively.Overlays of the representative Myc-
GRASP and ARF6-HA fluorescenceare shown in C, F, and I.J, Quantification of
cotransfected HEK293 cells that exhibit Myc-GRASP endosomallocalization.
Statistical significance at the 99% confidence level(p < 0.01) is indicated by **
symbols for comparison with values from cells transfected withGRASP alone. The
values represent the mean of three independent experiments in whicha minimum of 50
transfected cells were scored.that the frequency of GRASP localization in the endosomal compartment is indeed
related to the level of expression of the protein.
3.4.4Coexpression of GRP1 prevents GRASP localization in the endosomal
compartment
ARF6 nucleotide exchange has been hypothesized to occur on recycling
endosomes (D'Souza-Schorey, Li et al. 1995; Radhakrishna and Donaldson 1997; Al-
Awar, Radhakrishna et al. 2000; Donaldson and Radhakrishna 2001). As we have
shown that GRASP localization in the endosomal compartment is proportional to the
expression level of the protein, we hypothesized that this resulted from an inability of
the ARF6 GEF to be recruited to the endosomes to stimulate nucleotide exchange and
recycling. This would occur if endogenous levels of the ARF6 GEF were low and/or an
abundance of soluble GRASP sequestered the endogenous GEF in the cytosol,
preventing recruitment of the GEF to the endosome. To test this hypothesis, HEK293
cells were transfected with expression vectors encoding GRASP in the presence and
absence of an equivalent amount of GRP1, a GEF for ARF6 (Langille, Patki et al. 1999)
that we have previously shown interacts with GRASP (Nevrivy, Peterson et al. 2000).
Twenty percent of the cells transfected with GRASP alone exhibited a high degree of
GRASP endosomal staining (Figs. 3.4A and H).In contrast, only 2% of the cells
exhibited an accumulation of GRASP-positive endosomes when cotransfected with50
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Figure 3.3. High expression levels of GRASP contribute to
GRASP localization in the endsosomal compartment.
H1EK293 cells were transfected with increasing concentrations
of an expression vector encoding Myc-GRASP followed by
indirect immunofluorescence microscopy as described in the
legend of Figure 1 and scoring of transfected cells for the
presence of an accumulation of endosomes staining positively
for Myc-GRASP. Statistical significance at the 95% (p <
0.05) and 99% confidence level (p <0.01) is indicated by *
and **, respectively, for comparison with 0.5 j.tg GRASP
cDNA. The values represent the mean of three independent
experiments in which a minimum of 50 transfected cells were
scored.
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GRP1 (Fig 3.4H), suggesting that overexpression of GRP1 prevents an accumulation of
GRASP in the endosomal compartment. In the 2% of cells that exhibited an endosomal
localization of GRASP, a partial endosomal colocalization of GRP1 and GRASP was
observed (Figs. 3.4E-G), suggesting that GRASP recruits GRP1 to endosomes where
GRP1 may stimulate guanine nucleotide exchange on ARF6. Endosomal localization of
GRP 1 was not observed in the absence of GRASP under these experimental conditions
(data not shown).
3.4.5GRP1 catalytic activity is required to prevent the accumulation of
GRASP in the endosomal compartment
As activated ARF6 is required for plasma membrane recycling (DtSouza-
Schorey, Li et al. 1995; D'Souza-Schorey, van Donselaar et al. 1998; Al-Awar,
Radhakrishna et al. 2000) and GRP1 catalyzes nucleotide exchange on and activation of
ARF6 (Langille, Patki et al. 1999), we hypothesized that the catalytic activity of GRP1
may be required to prevent the accumulation of GRASP in the endosomal compartment.
To test this hypothesis, we examined the effect of coexpression of a catalytically
inactive mutant of GRP1, GRP1 E161K, on the subcellular distribution of GRASP. The
catalytically inactive mutant of GRP1, GRP1 E161K, is based on homology to the
catalytically inactive mutant of ARNO, ARNO E156K (Beraud-Dufour, Robineau et al.
1998), an ARF6 GEF that is highly related to GRP1. HEK293 cells were transfected103
with expression vectors encoding GRASP in the presence and in the absence of an
equivalent amount of expression vector encoding GRP 1 El 61K. Cells were visualized
by indirect immunofluorescence microscopy and scored for an accumulation of GRASP
in the endosomal compartment as described above. As observed previously, 20% of the
cells transfected with GRASP exhibited a high degree of endosomal staining (Figs.
3.5A and E) and co-expression of GRP1 E161K had no effect on the degree of
endosomal GRASP staining (18%, Fig. 3.5E), even though GRP1 E161K partially
colocalized with GRASP on endosomes (Fig. 3.5D). Control experiments revealed that
GRP 1 El 61K interacted with GRASP to a similar degree as wild-type GRP 1 in vitro
(Fig. 3.5F). These findings demonstrate that the guanine nucleotide exchange catalytic
activity of GRP1 is required to prevent GRASP accumulation in the endosomal
compartment.
3.4.6 The coiled-coil domain of GRP1 is required to prevent GRASP
accumulation in the endosomal compartment
HEK293 cells were transfected with expression vectors encoding truncation
mutants of GRP1 (Fig. 3.6A) to determine which domain(s) of GRP1 was required to
prevent GRASP accumulation in the endosomal compartment. Cells transfected with
GRASP alone exhibited GRASP endosomal staining to a degree observed previously
(approximately 20%; Figs. 3.6B and L) and coexpression with a GRP1 mutant lacking105
the coiled-coil region, GRP1-Sec7-PH, did not alter the percentage of cotransfected
cells in which GRASP-positive endosomes were observed (20 and 23%, respectively;
Figs. 3.6C-E and L), suggesting that the coiled-coil domain is necessary to rescue the
GRASP-mediated block in endosomal recycling. In contrast, coexpression of a GRP1
mutant containing the coiled-coil and Sec7 domain, GRP1 Coil-Sec7, significantly
reduced the extent of GRASP localization in the endosomal compartment (2% of cells;
Figs. 3.6F-H and L), as did coexpression of a GRP1 point mutant predicted to be
defective inPIP3binding, GRP1 R284D (Figs. 3.61-K and L), based on homology to a
PIP3binding-deficient mutant ARNO (Mukherjee, Casanova et al. 2001), suggesting
that neither the PH domain norPIP3binding by GRP1 is required to prevent GRASP
localization in the endosomal compartment.
3.4.7 Expression of the coiled-coil domain of GRP1 prevents GRASP
localization in the endosomal compartment
As we had observed that expression of GRP1 prevented GRASP from
accumulating in the endosomal compartment, we hypothesized that this occurred as a
result of the recruitment of GRP 1 to recycling endosomes by GRASP, resulting in
nucleotide exchange on ARF6 and recycling of the endosomes to the plasma membrane.
This hypothesis is supported by our data demonstrating that the catalytic activity of
GRP1 is required to prevent GRASP from accumulating in the compartment and that106
Figure 3.6.The coiled-coil domain of GRP1 is required to prevent GRASP
accumulation in the endsomal compartment.HEK293 cells were transiently
cotransfected with an expression vector encoding Myc-GRASP alone(B)or in
combination with expression vectors encoding either GRP1 Coil-Sec7(F-H)or GRP1-
Sec7-PH-HA (C-E), followed by visualization and scoring of transfected cells for
GRASP endosomal localization as described in the legend of Figure 1. GRP 1 Coil-Sec7
was detected with a goat anti-GRP1 polyclonal antibody (Santa Cruz). (A) schematic of
the GRP1 truncation mutants.B,HEK293 cells expressing Myc-GRASP alone.
Cotransfected cells shown in C,F,and I are representative cells stained with the Myc
antibody that indicate Myc-GRASP fluorescence while those shown in D, G, and J
correspond to cells stained with the HA or GRP1 antibodies representing GRP1-Sec7-
PH-HA, GRP1 Coil-Sec7, and GRP1 R284D fluorescence, respectively. Overlays of
the respective Myc-GRASP and GRP1 fluorescence are shown inE, HandK.L,
Quantification of cotransfected HEK293 cells that exhibit Myc-GRASP endosomal
localization. Statistical significance at the 99% confidence level (p < 0.01) is indicated
by ** symbols for comparison with values from cells transfected with GRASP alone.
The values represent the mean of three independent experiments in which a minimum
of 50 transfected cells were scored.GRP1-Sec7-PH, a mutant that lacks the coiled-coil responsible for interaction with
GRASP (Nevrivy, Peterson et al. 2000), failed to prevent GRASP from accumulatingin
the endosomal compartment.Therefore, we anticipated that coexpression of the
isolated coiled-coil region of GRP1 may lead toan enhancement of GRASP-positive
endosomes as the coiled-coil fragment of GRP1 would prevent endogenous ARF6
GEFs from being recruited to endosomes that contained GRASP. Totest this
hypothesis, HEK293 cells were transfected with an expression vector encoding GRASP
in the presence and absence of an expression vector encoding the GRP1 coiled-coil
region (Fig. 3.7A), followed by indirect immunofluorescence and scoring of transfected
cells as described above. GRASP exhibited an endosomal localizationto a degree
observed previously (Figs. 3.7B and I).Surprisingly, coexpression of the coiled-coil
domain of GRP1 with GRASP strongly inhibited GRASP localization in the endosomal
compartment (Figs. 3.7C-E) as only 2% of cotransfected cells exhibited an
accumulation of endosomes staining positively for GRASP (Fig. 3.71). In transfected
cells that exhibited GRASP accumulation in the endosomal compartment, colocalization
of GRP 1-coiled-coil and GRASP was observed (Figs. 3.7F-H).110
3.4.8Residues within the leucine rich region of GRASP specify endosomal
targeting
The above results suggest that GRASP targeting to the endosomal compartment
occurs independently of interaction with GRP1, and that GRASP is able to recruit
GRP1 to the endosome. In order to define the region(s) of GRASP responsible for
endosomal targeting, we examined the subcellular distribution of several GRASP
mutants by indirect immunofluorescence microscopy and found that only constructs
harboring the leucine rich region localized in endosomes (data not shown).
Additionally, a construct corresponding to the leucine rich region of GRASP (amino
acids 180-257) fused to GFP (Fig. 3.8A) accumulated in the endosomal compartment in
a manner similar to that of wild-type GRASP (Fig. 3.8B and F).Moreover, the
localization of GFP-GRASP 180-257 was coincident with that of ARF6 N1221 (Fig.
3.8C-E), suggesting that residues within the leucine rich domain are necessary and
sufficient to induce a block in the ARF6 recycling pathway. Coexpression of either
wild-type GRP1 or GRP1 mutants (Fig. 3.8F) prevented GFP-GRASP 180-257 from
accumulating in the endosomal compartment as we previously observed in the case of
wild-type GRASP (Compare Figs. 3.4-7 with Fig. 3.8F). These results demonstrate that
residues within the leucine rich region (amino acids 180-257) of GRASP are necessary
and sufficient to target GRASP in the endosomal compartment.111
Figure 3.8. Residues within the leucine rich region of GRASP specify endosomal
targeting.HEK293 cells were transiently cotransfected with an expression vector
encoding GFP-GRASP 180-257 in the absence and in the presence of an expression
vector encoding ARF6 N1221-HA or GRP1 and mutants, followed by visualization of
transfected cells by fluorescence microscopy. A, Schematic of GFP-GRASP 180-257.
B, HEK293 cells expressing GFP-GRASP 180-257. C, HEK293 cells expressing both
GFP-GRASP 180-257 and ARF6 N 1221-HA, detecting only GFP-GRASP 180-257. D,
HEK293 cells expressing both GFP-GRASP 180-257 and ARF6 Nl221-HA, detecting
only ARF6 N 1221-HA. E, an overlay of the fluorescence from panels B and C. F,
Quantification of cotransfected HEK293 cells that exhibit an accumulation of GFP-
GRASP 180-257 in the endosomal compartment. Statistical significance at the 99%
confidence level (p <0.01) is indicated by ** symbols for comparison with values from
cells transfected with GFP-GRASP 180-257 alone. The values represent the mean of
three independent experiments in which a minimum of 50 transfected cells were scored113
3.4.9 Residues within amino acids 180-230 of GRASP are required to
mediate interaction with GRP1
Our results indicated that residues within the leucine rich regionwere
responsible for the endosomal localization of GRASP. This finding was somewhat
unexpected, as we have shown previously that this region interacts with the ARF6
exchange factors GRP1 and ARNO (Nevrivy, Peterson et al. 2000). These findings
suggest the existence of at least two functional domains within the leucine rich region:
one specifying interaction with cytohesins, and the other conferring GRASP
localization in the endosomal compartment. Alternatively, interaction with cytohesins
may be required for endsomal targeting of GRASP. Thus, we conducted experiments to
determine if these two functional domains were separable. First, we sought to identify
the regions within the leucine rich domain of GRASP (see Fig. 3.9A) that specified
interactionwithGRP1bycoimmunoprecipitationanalyses.GRP1
coimmunoprecipitated with GFP-GRASP 180-230 to a degree at least equal to that of
GFP-GRASP 180-257, indicating that residues within amino acids 180-230 are
sufficient for interaction with GRP1 (Fig. 3.9B; compare lanes 13 and 12). In contrast,
GRP1 did not coimmunoprecipitate with GFP-GRASP 231-392 (Fig 3.9B, lane 14).
These results demonstrate that GRASP residues 180-230 are necessary and sufficient
for interaction with GRP 1.114
We next attempted to define more precisely which residues within amino acids
180-230 of GRASP mediated the interaction with GRP1.Secondary structural
predictions predicted the presence of a coiled-coil motif spanning residues 191-207
(data not shown). Because coiled-coil motifs are common oligomerization motifs, and
because we have shown previously that GRASP interacts with residues within the
coiled-coil region of GRP1 (Nevrivy, Peterson et al. 2000), we determined if this region
was sufficient to interact with GRP 1. In addition, a construct encoding the other half of
the GRASP leucine rich region was tested for the ability to interact with GRP1 in
transfected cells. GRP1 did not coimmunoprecipitate with either GFP-GRASP 191-
207, or GFP-GRASP 208-392 (Fig. 3.9C, lane 7 and 8, respectively), however, GRP1
did coimmunoprecipitate with GFP-GRASP 180-230 to a degree observed previously
(Fig. 3.9C, lane 6). Control experiments demonstrated expression levels of the GFP-
GRASP fusion proteins were equivalent (data not shown). These results suggest that the
URP1 interaction domain of GRASP is extensive and likely spans a large part of the
leucine rich region, amino acids 191-207 and 208-230.
3.4.10Residues within amino acids 208-230 of GRASP are necessary for
theendosomal targeting of GRASP
We next determined which region within the leucine rich region of GRASP
(residues 180-257) was responsible for targeting GRASP to the endosome. Three115
Figure 3.9.Residues within amino acids 180-230 of GRASPare required to
mediate interaction with GRP1. Whole cell lysates fromHEK293 cells transfected
with the indicated expression vectors (3.0.Lg each) were immunoprecipitated using a
rabbit anti-GFP polyclonal antibody.Immunoprecipitates were then subjected to
immunoblot analysis using an antibody directed against GRP 1.A, Schematic of the
GFP-GRASP truncation mutants. B, Coimmunoprecipitation analysisof GRP1 and
GFP-GRASP 180-230 and 231-392 truncation mutants.C, Coimmunoprecipitation
analysis of GRP1 and GFP-GRASP 180-230, 19 1-207, and 208-392.117
GRASP mutants encoding residues 180-257, 180-230, and 208-392 localized in the
endosomal compartment to varying degrees. GRASP 180-257 exhibited endosomal
localization in approximately 25% of cells (Figs. 3.1OA and F), consistent with previous
results (see Figs. 3.8B and F) and to an extent similar to that of wild-type GRASP (Figs.
3.1-7). In contrast, while both GRASP 180-230 (Figs. 3.1OB and F), and GRASP 208-
392 (Figs 3.1OD and F) localized in endosomes, these mutants did so much less
frequently, 5 and 3%, respectively, than either wild-type GRASP or GRASP 180-257.
Two GRASP mutants harboring different subregions of the leucine-rich region, GRASP
191-207 (Figs. 3.1OC and F) and GRASP 231-392 (Figs. 3.1OE and F) did not
detectably localize in endosomes. The expression level of all GRASP mutants was
similar as verified by immunoblotting (data not shown).
Considered together, these results imply that GRASP amino acids 208-230,
which are required for interaction with GRP1 (Fig. 3.9B), harbor an endosomal
targeting signal. However, there are two caveats to this interpretation. First, it is clear
that amino acids flanking this minimal endosomal targeting signal, i.e., GRASP amino
acids 180-207 and 23 1-257, affect the frequency with which GRASP is targeted to the
endosomal compartment. This is most obvious in the latter case as addition of residues
231-257 to GRASP 180-230 resulted in a 5-fold increase in endosomal targeting (Fig.
3.1OF). However, the contribution of GRASP amino acids 180-207 was also implied by
the reduced endosomal targeting efficiency of GRASP 208-392 (3% frequency; Figs.118
3.1OD and F) compared to GRASP 180-257 (25% efficiency; Figs. 3.1OA and F).
Second, the use of these mutants revealed that it was possible to separate the ability of
GRASP to interact with GRP1 from endosomal targeting of GRASP, at least partially.
This interpretation is based on two observations: (1) GRASP 180-230 interacted with
GRP1 at least as efficiently as GRASP 180-257 (Fig. 3.9B), but was targeted to
endosomes at a frequency 5-fold less than that of wild-type GRASP (Figs. 3.1-7)or
GRASP 180-257 (Figs. 3.1OA and F), and (2) GRASP 208-392, which did not interact
with GRP1 in cells (Fig. 3.9C), was targeted to endosomes (Figs. 3.1OD and F), albeit
with a reduced frequency than that of either wild-type GRASP or GRASP 180-257.
Thus, it appears that efficient endosomal targeting of GRASP requires interaction with
GRP 1, or other cytohesin family members, that is conferred by GRASP amino acids
180-230, and GRASP amino acids 23 1-257 which serve an unknown function.
3.4.11 Amino acids 231-262 target GRASP to the cell periphery rich in
cortical actin
We observed that GFP-GRASP 180-230 did not localize in the endosomal
compartment at the same frequency compared with that of GFP-GRASP 180-257, even
though this mutant interacted with GRP1 to a similar degree. We hypothesized that the
reduced frequency may be due to an inefficiency of this mutant in entering the ARF6
recycling pathway compared with that of GFP-GRASP 180-257. This would120
necessitate that residues 23 1-257 are involved in facilitating GRASP entry into the
recycling pathway. Curiously, we observed that GFP-GRASP 231-392, a mutant that
was not observed in the endosomal compartment, localized predominantly at the cell
periphery in what appeared to be cortical actin-based structures (Fig. 3. bE). A similar
localization has been observed with full-length GRASP, although to a lesser degree
(data not shown), suggesting that the localization of the mutant is not artifactual and
may arise out of an inability to become internalized on endsomes.Therefore, we
determined if residues within amino acids 23 1-262 were required to target GRASP to
the cell periphery. HEK293 cells were transfected with expression vectors encoding
GFP-GRASP 231-392 or GFP-GRASP 263-392 (Fig 3.11A) and visualized by
fluorescence microscopy.Cells were counterstained with rhodamine-phalloidin to
visualize filamentous actin. As observed previously, GFP-GRASP 231-392 localized at
the cell periphery (Fig. 3.1 1B) and GFP fluorescence was coincident with cortical actin
(Figs. 3.1 lB-D).In addition, the fusion protein exhibited substantial colocalization
with short actin filaments that appeared to be distributed at the cell surface (Fig. 3.1 1D).
In contrast, GFP-GRASP 263-392 did not localize at the cell periphery or with actin-
based structures, but appeared to be restricted to the cytosol and the nucleus, where
large globular aggregates of the fusion protein were observed (Fig. 3.11 E-G). The
molecular basis for the aberrant, nuclear distribution of GRASP 263-392 is unknown
but may be artifactual arising only when all other targeting signals are removed. These121
results demonstrate that residues within amino acids 23 1-262 of GRASPare required
for localization at the cell periphery and actin-basedstructures, and suggest that
localization to these areas may be an important determinant in facilitatingentry of
GRASP into an ARF6-mediated recycling pathway.
3.5Discussion
Overexpressed GRASP was found to exhibit a punctate juxtanuclear localization
in HEK293 cells that resembled the recycling endosomalcompartment in which GTP-
binding mutants of ARF6 reside (D'Souza-Schorey, Li et al. 1995). Coexpression of
GRASP and ARF6 N1221 increased the degree to which GRASP localized in the
endosomal compartment, indicating that GRASP and ARF6 likely function in identical
or highly related plasma membrane recycling pathway(s).
Numerous studies have demonstrated that overexpression of ARF6 T27N,a
GTP-binding mutant similar to ARF6 N 1221, results inan accumulation of recycling
endosomes and a block in endosomal recycling (D'Souza-Schorey, Li et al. 1995;
Radhakrishna and Donaldson 1997; D'Souza-Schorey, van Donselaar et al. 1998). We
propose that GRASP may induce a similar block in recycling based on the following
observations: (1) in cells that exhibited an endosomal localization of GRASP, the
morphology of the endosomal compartment was indistinguishable from that of cells123
expressing ARF6 N 1221, (2) the accumulation of GRASP-positive endosomeswas a
function of the level of GRASP expression, and (3) coexpression of GRP1,but not a
catalytically inactive mutant, dramatically reduced the accumulation of GRASPin the
endosomal compartment.
Coexpression of constitutively active ARF6, ARF6 Q67L, with GRASP didnot
affect the endosomal localization of GRASP. Thiswas unexpected considering that in
TRVb- 1 cells expressing ARF6 Q67L, transferrin receptors constitutivelylocalize at the
cell membrane and are neither internalizednor exhibit endosomal localization
(D'Souza-Schorey, Li et al. 1995). Furthermore,an ultrastructural analysis of cells
expressing ARF6 Q67L revealed a virtual absence of endosomes in the cell (Peters, Hsu
et al. 1995). In contrast, in the presence of overexpressed GRASP, ARF6 Q67L does
not appear to affect the endosomal system to the same degree, as structures indicative of
endosomes were clearly both evident and abundant. One explanation for thisapparent
discrepancy would involve GRASP acting in concert with the endogenous ARF6 in
promoting endocytosis. Alternatively, this observation would also be consistent with
GRASP overexpression exerting a dominant negative effecton ARF6 signaling in the
cell, in a manner that is similar to overexpression of GTP binding-deficientmutants of
ARF6. ARF6 GTP binding deficient mutants, suchas ARF6 T27N and ARF6 N1221,
are thought to exert their dominant negative effects by binding to and sequestering
GEFs (Boguski and McCormick 1993).As we observed that the endosomal124
localization of GRASP was dependent on high expression levels of the protein, we
hypothesized that this occurred due to limiting GEF concentrations in the cell and a
failure of the GEF to be recruited to endosomes and stimulate nucleotide exchange,
resulting in an accumulation of endosomes and a block in recycling.Under these
circumstances, accessibility of the GEF to the ARF6 Q67L mutant would be reduced
and effects of the mutant diminished. Also, it is noted that interpretation of these results
may be further complicated by the use of epitope-tagged versions of ARF6 and ARF6
mutants, which may function inefficiently relative to native proteins and this may have
affected the ability of ARF6 mutants to exert a dominant phenotype (Radhakrishna, Al-
Awar et al. 1999; Al-Awar, Radhakrishna et al. 2000).
Numerous studies have supported the view that the ARF6 cycle may be unique
amongst ARFs in that ARF6 does not cycle between membrane and soluble forms, but
rather is constitutively bound to membranes regardless of its GTP status (Cavenagh,
Whitney et al. 1996). ARF6 is thought to cycle between a plasma membrane and GTP-
bound state and intracellular vesicle and GDP-bound state.However, we did not
observe localization of wild-type ARF6 in the endosomal compartment in the presence
or absence of GRASP. In contrast, colocalization of ARF6 N1221 and GRASP was
clearly observed in the endosomal compartment. These observations may suggest that
ARF6 does not remain constitutively bound to membranes throughout its GTP/GDP
cycle, and may require recruitment by the ARF6 GEF to recyling endosomes to become125
activated.In support of this notion, it has been demonstrated that ARF6 is recruited
along with ARNO from the cytosol to proximal tubule endosomes ina pH-dependent
manner (Maranda, Brown et al. 2001), which has been speculated to result in nucleotide
exchange of ARF6 and endosomal fusion with the plasma membrane(Maranda, Brown
et al. 2001).In addition, it has been shown that membrane-bound ARF6 could be
released into the cytosol upon incubation in buffers containingphysiologic
concentrations of magnesium, supportinga mechanism of membrane to cytosol
shuttling of ARF6 (Gaschet and Hsu 1999).As our results suggest that the
accumulation of GRASP in the endosomal compartment arises dueto limiting ARF6
GEF concentrations in the cell, the absence of ARF6on the endosomal compartment
would be consistent with a mechanism of ARF6 recruitmentto recycling endosomes by
an ARF6 GEF. However, it is important to consider that ARF6 mechanisms of plasma
membrane recycling may vary dependingon the nature of internalized cell surface
proteins, the cell type, and the presence/absence of regulatory proteins. Thisis
highlighted by the fact that ARF6 regulates the transferrin receptor recycling pathway in
CHO (D'Souza-Schorey, Li et al. 1995), but not HeLa cells (Radhakrishna, Klausneret
al. 1996; Radhakrishna and Donaldson 1997). In addition, it is possible thatour failure
to visualize ARF6 in the endosomal compartment with GRASPmay be due to the use
of an epitope-tagged ARF6, which may internalize less efficiently than the endogenous
ARF6. Although we did not observe ARF6 costainingon the endosomal compartment126
with GRASP, it is also possible that ARF6 localization in the endosomalcompartment
was beyond our limits of detection in this experiment.
Our hypothesis that the endosomal localization of GRASP results from titration
of ARF6 GEFs and/or sequestration of endogenous ARF6 GEFs in the cytosol is
supported by our finding that coexpression of an ARF6 GEF, GRP 1, dramatically
reduced the accumulation of GRASP-positive endosomes.However, neither
catalytically inactive GRP1 nor a GRP1 mutant lacking the GRASP-interaction domain
rescued the GRASP-positive endosomal phenotype. These findings suggest that ARF6-
mediated endosomal recycling requires at least: (1) GRASP-GRP 1 complex formation
on endosomes and (2) GRP1-catalyzed nucleotide exchange on ARF6.
Overexpression of ARNO3, the human homologue of GRPI, did not result in
redistribution of transferrin receptors from the recycling endosomal compartment to the
plasma membrane of TRNb- 1 cells (Franco, Peters et al. 1999), suggesting that ARNO3
does not function as an ARF6 GEF in transferrin receptor recycling.It would be of
interest to determine if ARNO3 regulates transferrin receptor recycling in TRNb- 1 cells
when GRASP is present as our results in HEK293 cells clearly implicatea role for
GRP1 in a recycling pathway regulated by ARF6. Coupling of GRASP and GRP1, on
the other hand, may result in the targeting of specific classes of cell surface proteins for
the ARF6-regulated recyling pathway.127
We did not expect that expression of the coiled-coil fragment of GRP1 would
prevent the accumulation of GRASP in the endosomal compartment.Rather, we
anticipated that the coexpression of the isolated GRP1 coiled-coil would leadto an
enhancement of GRASP localization in the endosomal compartment. Thiswas based
on our assumption that the coiled-coil region of GRP1 would function as a dominant
negative inhibitor of endogenous cytohesins in H1EK293 cells. Thus,we expected that
the GRP1 coiled-coil region would bind to GRASPon endosomes and block access of
endogenous cytohesins at this locus resulting in decreased GEF-catalyzed nucleotide
exchange on ARF6, compromised endosomal recycling to the plasma membrane, and
accumulation of GRASP-positive endosomes. The lack of GRASP localization in the
endosomal compartment in the presence of GRP1-coiled-coil appears to be in conflict
with our hypothesis that GRASP recruits GRP1 to the endosomal compartment, and
rather suggests that GRP 1, or perhaps other cytohesins recruit GRASP to endosomes.
However, our data clearly indicate that GRASP recruits GRP1 to the endosomal
compartment because: (1) localization of GRP1 and fragments of GRP1 containing the
coil-coil domain were observed on endosomes in the presence, but not in the absence of
GRASP, (2) a GRASP mutant, GFP-GRASP 208-392, was unable to interact with
GRP1 in extracts of transfected cells yet this mutant localized in the endosomal
compartment, at least partially, and (3) we were unable to detect endogenous GRP1 or
ARNO localization in the endosomal compartment when GRASP was present (data not128
shown). Taken together, our data indicate that GRASP localizes inthe endosomal
compartment independently of GRP1 and is able to recruit GRP1 to the endosomal
compartment.
Because overexpression of the coiled-coil fragment of GRP1 would be predicted
to function in a dominant negative manner by preventing GRASP from interacting with
endogenous cytohesins, our data therefore suggest that interaction of GRASPwith
endogenous cytohesins at a stage in the ARF6 recycling pathway priorto trafficking to
the endosomal compartment appears to facilitate GRASP localizationin this
compartment. Indeed, our results demonstrate that GFP-GRASP 208-392, which failed
to interact with GRP1 by coimmunoprecipitation analyses, localized in the endosomal
compartment at a reduced frequency compared with that of GFP-GRASP 180-257,
which we have shown interacts with GRP1. These findingssupport our hypothesis that
GRASP interaction with GRP1, or other cytohesins, ata stage in the recycling pathway
upstream of trafficking to the endosomal compartment facilitates the localization of
GRASP in this compartment.
A key question that arose from these results is how GRASP enters the recycling
pathway. We observed that GFP-GRASP 180-230, which interacted with GRP1to a
similar degree as GFP-GRASP 180-257, localized in the endosomalcompartment at a
reduced frequency (5% versus 25%; Fig. 3. 1OF). These results suggested that amino
acids 231-257 of GRASP may play a role in increasing the frequencyat which GRASP129
localized in the endosomal compartment. Our results indicated these residues (amino
acids 231-262 of GRASP) were required to target GRASP to the cell periphery and
cortical actin-containing structures.As endosomes are derived from the plasma
membrane, it seems reasonable to speculate that localization of GRASPto cortical
areas, mediated by amino acids 23 1-262, may represent an early event regulating entry
of GRASP into the ARF6 recycling pathway, ultimately leadingto internalization of
GRASP at the plasma membrane and localization in the endosomalcompartment. Our
results demonstrating that GFP-GRASP 180-230 exhibiteda reduced frequency of
localization in the endosomal compartment, may therefore be due toan inability of this
mutant to be targeted to the cell periphery and cortical areas, resulting in a reduced
capacity to enter the ARF6 recycling pathway.
Our results, therefore, suggest that in addition to interaction with cytohesins,
proper targeting of GRASP to the cell periphery is required to facilitate GRASP entry
into the ARF6 recycling pathway. We envision that the targeting of GRASP to cortical
areas results in the recruitment of a cytohesin and, ultimately, ARF6 (Fig. 3.12) to these
loci. This juxtaposition of GRASP and ARF6 may ultimately lead to the internalization
of GRASP on ARF6-containing endosomes during GTPase activating protein (GAP)-
catalyzed hydrolysis of ARF6-GTP. Because we observe that GRASP localizes in the
endsomal compartment independently of GRP 1, we propose that, at some stage in the
ARF6 recycling pathway prior to trafficking to the endosomal compartment, there isan130
uncoupling of the GRASP-GRP1 interaction. Interestingly, there exist putative
phosphorylation sites on serine, threonine, and tyrosine within residues 189-230 of
GRASP (data not shown), which encompasses the region of interaction with GRP1.
Such an uncoupling would allow the newly liberated GRP1 to bind additional GRASP
proteins, perhaps at the plasma membrane to begin a new round of ARF6 recruitment
and internalization. Multiple rounds of uncoupling and internalization, may lead toan
accumulation of GRASP in the endosomal compartment. If GRASP expression levels
are high due to transient transfection or, perhaps RA treatment, soluble GRASP may
sequester GRP1 at cytoplasmic loci. This may compromise the function of GRP1 in
catalyzing nucleotide exchange on and activation of ARF6 at the level of the endosome,
resulting in a block in endosomal recycling to the plasma membrane.
Although our results do not support a role for either the GRP 1 PH domain, or
PIP3binding by GRP 1 in the regulation of the ARF6 recycling pathway in the presence
of GRASP, it is important to note that our results were generated in cells under non-
stimulated conditions.Therefore, we cannot rule out the possibility that under
conditions of P1 3-kinase activation, GRASP may enter the recycling pathway via
recruitment by a cytohesin at the plasma membrane. Indeed, we observed that GFP-
GRASP 180-230 localized in the endosomal compartment at a reduced frequency,
presumably because this mutant lacked residues necessary for proper targeting to the
cell periphery.It will be of interest to determine if this mutant enters the recycling131
pathway through PIP3-dependent recruitment of cytohesin-GRASP complexes to the
plasma membrane.
A broader question relates to the central function of GRASP in the ARF6 cycle.
GRASP harbors a PDZ domain in the amino terminal region of the protein, and these
domains have been shown to bind short C-terminal sequences present innumerous
transmembrane receptors (Harris and Lim 2001).Interestingly, the PDZ domain-
mediated interaction of NHERFIEBP5O with the 132 adrenergic receptor (132-AR) has
been shown to be essential for recycling of the receptor following agonist-induced
endocytosis (Cao, Deacon et al. 1999). Disruption of the interaction, likely through
phosphorylation of the C-terminal tail of the receptor, directs the receptor to the
lysosome for degradation (Cao, Deacon et al. 1999). Furthermore, incorporation of the
PDZ binding motif of the 132-AR into the nonrecycling delta opioid receptor, redirects
that receptor to recycle, implicating the PDZ binding motif of the 132-AR as a bona fide
sorting signal (Gage, Kim et al. 2001). The presence of a PDZ domain in GRASP,
coupled with our observations demonstrating GRASP participates in the ARF6
recycling pathway, would make GRASP an ideal candidate to target receptors for the
recycling pathway.
GRASP was originally identified as a retinoic acid-induced gene product
(Nevrivy, Peterson et al. 2000). We consistently observed 15-20-fold induction of132
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Figure 3.12. Proposed mechanism of GRASP action in regulating
the ARF6 plasma membrane recycling pathway. GRASP is pre-
dicted to enter the pathway by recruitment of GRPI (or other
cytohesins), followed by ARF6 to plasma membrane loci. Following
hydrolysis of ARF6-GTP, GRASP along with ARF6-GDP is internal-
ized and localizes in the endosomal compartment. GRASP accumu-
lates in this compartment when levels of GRP1 are low and/or GRP1
is sequestered in the cytosol by GRASP. Recruitment of GRPI to the
GRASP-positive endosomes is predicted to result in nucleotide
exchange on ARF6-GDP and trafficking of the endosome to the plas-
ma membrane.133
GRASP transcripts during RA-induced differentiation of P19 cells (Nevrivy, Peterson et
al. 2000). As our data suggest that the block in recycling induced by GRASP is due to a
stoichiometric imbalance of GRASP and an ARF6 exchange factor, it will also be of
interest to determine if GRASP induction by RA results in a similar imbalance and
effect on the ARF6 cycle during RA-induced cellular differentiation.
3.6Abbreviations
The abbreviations used are: GRP1, general receptor for phosphoinositides 1;
ARF, ADP-ribosylation factor; ARNO,F nucleotide-binding site site Qpener; GST,
glutathione S-transferase; GEF, guanine nucleotide exchange factor; GAP, GTPase
activating protein; PH, pleckstrin humology; SH3, Src homology 3; BFA, brefeldin A;
HEK, human embryonic kidney; GFP, green fluorescent protein.
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Chapter 4
Summary
Retinoic acid is known to exert profound effects on development and
differentiation in a wide variety of systems (Gudas 1994) and isalso used
therapeutically in the treatment of various skin diseases (Schaefer and Reichert 1990)
and acute promyelocytic leukemia (Huang, Ye et al. 1988).RA has also shown
effectiveness in the prevention and treatment of many other cancers mediated by its
effects on growth inhibition and induction of differentiation to nonneoplastic
phenotypes (Bollag and Holdener 1992) although the teratogenic effects of retinoids
and acquisition of resistance greatly limit the efficacy of retinoids in many of these
systems. Therefore, a greater understanding of the cellular and molecular mechanisms
of action of RA may aid in the development of more effective treatments, and
contribute additional knowledge towards an understanding of the role of retinoids in the
control of cellular and developmental processes. The studies described herein were
designed to contribute additional knowledge of the cellular mechanisms of action of RA
through the identification and functional characterization of a novel retinoic acid-
induced gene from P19 embryonal carcinoma cells.140
GRASP was identified as a novel RA-induced gene and induction of GRASP
transcripts were observed within 2 hrs. of RA treatment. GRASP was also induced by
RA in the presence of cycloheximide, albeit to a reduced degree, suggesting that
GRASP may be a direct target gene of RA in P19 cells.Analysis of the predicted
amino acid sequence of GRASP revealed that GRASP contained several known protein-
protein interaction motifs, suggesting that GRASP may function as an adapter protein in
signal transduction pathways.Therefore, towards the goal of identifying which
signaling pathways GRASP may be involved in, we utilized a two-hybrid screen and
identified GRP1 as a GRASP interaction partner. GRASP was found to enhance GRP1
association with the plasma membrane and colocalize with endogenous ARFs.
Upon overexpression, GRASP was observed to accumulate in an intracellular
endosomal compartment where GTP-binding deficient mutants of ARF6 reside,
suggesting that GRASP induced a block in the ARF6 plasma membrane recycling
pathway.Coexpression of ORP1 dramatically reduced the capacity of GRASP to
accumulate in this compartment, whereas neither a catalytically inactive mutant of
GRP1 nor a GRP1 mutant that lacked the region of interaction with GRASP affected the
accumulation of GRASP in this compartment. These results support the hypothesis that
the accumulation of GRASP in the endosomal compartment was due to an inability of
GRP1 to be recruited to the endosome to stimulate nucleotide exchange on ARF6 and
recycling. Regions within GRASP were identified that dictated efficient accumulation141
of GRASP in the endosomal compartment, and these residues also dictated interaction
with GRP1 and localization of GRASP to cortical actin-based structures at the cell
periphery.
These results support a model of GRASP mediated recruitment of GRP1 and
ARF6 to plasma membrane loci to initiate endocytosis and recycling. Furthermore, as
GRASP contains common protein-protein interaction motifs that are known to bind
receptors at the cell surface, our results support a role for GRASP in targeting cell
surface receptors for the ARF6 recycling pathway. In light of results demonstrating that
the expression level of GRASP influences endosomal recycling, GRASP may be
predicted to exert a biphasic effect on this pathway. At concentrations of GRASP that
do not exceed that of GRP1 (or other cytohesins) in the cell, GRASP expression would
be predicted to direct endosomal components for the recycling pathway, as GRASP
would recruit GRP1 to the endosome, resulting in nucleotide exchange of ARF6 and
recycling to the plasma membrane.In contrast, at high concentrations of GRASP
(relative to GRP1), GRASP would accumulate in the endosomal compartment and
endosomal components would not recycle to the plasma membrane. In either scenario,
RA induction of GRASP would be predicted to significantly modulate both the
amplitude and kinetics of signaling pathways regulated by plasma membrane receptors
to which GRASP binds, mediated by changes in occupancy of the receptors at the cell
surface.Such alterations, as have been demonstrated for a number of cell surface142
receptors (Waterman and Yarden 2001), may have significance in the regulation of
cellular and developmental processes by RA.
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